| QV307763 |
Vitamin D3 Octanoate
CAS# 927822-16-0
M.F.: C35H58O2
M.W.: 510.83 |
|
 |
| QV307762 |
Vitamin D3 Decanoate
CAS# 158180-04-2
M.F.: C37H62O2
M.W.: 538.89 |
|
|
| QD160763 |
Dapagliflozin Impurity 63
CAS# NA
M.F.: C27H33ClO12
M.W.: 585.00 |
|
|
| QD160762 |
Dapagliflozin Impurity 62
CAS# NA
M.F.: C21H25ClO6
M.W.: 408.87 |
|
|
| QD160761 |
Dapagliflozin Impurity 61
CAS# NA
M.F.: C21H25ClO6
M.W.: 408.87 |
|
|
| QE201308 |
Etomidate impurity 8
CAS# NA
M.F.: C20H30BrNO6
M.W.: 460.36 |
|
|
| QO201544 |
Vortioxetine Impurity 18
CAS# 1293489-77-6
M.F.: C18H22N2S
M.W.: 298.45 |
|
|
| QT130109 |
Temazepam Impurity 9
CAS# NA
M.F.: C16H13ClN2O2
M.W.: 300.74 |
|
|
| QT130108 |
Temazepam Impurity 8
CAS# 17311-35-2
M.F.: C16H13ClN2O2
M.W.: 300.74 |
|
|
| QK201634 |
Ketoprofen Impurity 34
CAS# 2098704-07-3
M.F.: C26H32O3
M.W.: 392.53 |
|
|
| QK201633 |
Ketoprofen Impurity 33
CAS# 2098704-06-2
M.F.: C26H32O3
M.W.: 392.53 |
|
|
| QK201632 |
Ketoprofen Impurity 32
CAS# 1853132-06-5
M.F.: C26H32O3
M.W.: 392.53 |
|
|
| QM031624 |
Mycophenolate Impurity 24
CAS# 26644-06-4
M.F.: C17H20O7
M.W.: 336.34 |
|
|
| QR051346 |
Remdesivir Impurity 46
CAS# 1911578-74-9
M.F.: C12H14N5O7P
M.W.: 371.24 |
|
|
| QF121408 |
Flunarizine Impurity 8
CAS# NA
M.F.: C26H26F2N2O2
M.W.: 436.49 |
|
|
| QT031859 |
D-alfa-Tocopherol Acetate
CAS# 58-95-7
M.F.: C31H52O3
M.W.: 472.74 |
|
|
| QD050214 |
Decitabine Impurity 14
CAS# NA
M.F.: C5H10O4
M.W.: 134.13 |
|
|
| QP122419 |
Plerixafor Impurity S
CAS# NA
M.F.: C14H22F6N4O2 2HCl
M.W.: 392.34 72.92 |
|
|
| QD050213 |
Decitabine Impurity 13
CAS# 96761-00-1
M.F.: C5H8O3
M.W.: 116.12 |
|
|
| QD050212 |
Decitabine Impurity 12
CAS# 863396-35-4
M.F.: C6H12O4
M.W.: 148.16 |
|
|
| QO192067 |
Oseltamivir Impurity 67
CAS# NA
M.F.: C22H32N2O6
M.W.: 420.50 |
|
|
| QN162440 |
Naproxen Impurity 40
CAS# NA
M.F.: C19H24O4
M.W.: 316.39 |
|
|
| QI242614 |
Ixazomib Impurity N
CAS# NA
M.F.: C20H23BCl2N2O9
M.W.: 517.12 |
|
|
| QZ161834 |
Ziprasidone Impurity 34
CAS# NA
M.F.: C18H14Cl2N2O2
M.W.: 361.22 |
|
|
| QZ161833 |
Ziprasidone Impurity 33
CAS# NA
M.F.: C10H11Cl2NO2
M.W.: 248.11 |
|
|
| QZ161832 |
Ziprasidone Impurity 32
CAS# NA
M.F.: C10H9Cl2NO
M.W.: 230.09 |
|
|
| QA164154 |
Avanafil Impurity 28
CAS# 36167-94-9
M.F.: C8H9Cl2NO
M.W.: 206.07 |
|
|
| QO132380 |
Omeprazole Impurity 80
CAS# NA
M.F.: C26H30N4O3S
M.W.: 478.61 |
|
|
| QL041607 |
Levodopa Impurity 7
CAS# 300-48-1
M.F.: C10H13NO4
M.W.: 211.21 |
|
|
| QR141221 |
Ranolazine Impurity U
CAS# NA
M.F.: C24H32N4O4
M.W.: 440.54 |
|
|
| QR141220 |
Ranolazine Impurity T
CAS# NA
M.F.: C14H21N3O2
M.W.: 263.34 |
|
|
| QC0303116 |
Cinacalcet Impurity 116
CAS# 585-50-2
M.F.: C10H9F3O2
M.W.: 218.17 |
|
|
| QC0303115 |
Cinacalcet Impurity 115
CAS# 113048-69-4
M.F.: C10H9F3O
M.W.: 202.17 |
|
|
| QC0303114 |
Cinacalcet Impurity 114
CAS# 111171-94-9
M.F.: C10H14O
M.W.: 150.22 |
|
|
| QC0303113 |
Cinacalcet Impurity 113
CAS# 67646-72-4
M.F.: C11H11F3O
M.W.: 216.20 |
|
|
| QC0303112 |
Cinacalcet Impurity 112
CAS# 103-25-3
M.F.: C10H12O2
M.W.: 164.20 |
|
|
| QC0303111 |
Cinacalcet Impurity 111
CAS# 29417-96-7
M.F.: C11H14O2
M.W.: 178.23 |
|
|
| QR141219 |
Ranolazine Impurity S
CAS# NA
M.F.: C34H52N6O5
M.W.: 624.81 |
|
|
| QC0303110 |
Cinacalcet Impurity 110
CAS# NA
M.F.: C20H18F3N
M.W.: 329.36 |
|
|
| QC0303109 |
Cinacalcet Impurity 109
CAS# 29690-38-8
M.F.: C15H13F3O3S
M.W.: 330.32 |
|
|
| QC0303108 |
Cinacalcet Impurity 108
CAS# 131086-40-3
M.F.: C14H11F3O3S
M.W.: 316.30 |
|
|
| QC0303107 |
Cinacalcet Impurity 107
CAS# 2055116-43-1
M.F.: C17H15F3O3S
M.W.: 356.36 |
|
|
| QC0303106 |
Cinacalcet Impurity 106
CAS# 217483-10-8
M.F.: C17H20O3S
M.W.: 304.40 |
|
|
| QC0303105 |
Cinacalcet Impurity 105
CAS# 3742-75-4
M.F.: C16H18O3S
M.W.: 290.38 |
|
|
| QC0303104 |
Cinacalcet Impurity 104
CAS# 1079988-51-4
M.F.: C11H13F3
M.W.: 202.22 |
|
|
| QC0303103 |
Cinacalcet Impurity 103
CAS# NA
M.F.: C11H13F3O2
M.W.: 234.21 |
|
|
| QC0303102 |
Cinacalcet Impurity 102
CAS# NA
M.F.: C11H13F3O
M.W.: 218.22 |
|
|
| QC0303101 |
Cinacalcet Impurity 101
CAS# 87087-35-2
M.F.: C11H9F3O2
M.W.: 230.18 |
|
|
| QI200340 |
Irinotecan Impurity 40
CAS# NA
M.F.: C15H16N2O4
M.W.: 288.30 |
|
|
| QI200339 |
Irinotecan Impurity 39
CAS# NA
M.F.: C17H21NO5
M.W.: 319.35 |
|
|
| QI200338 |
Irinotecan Impurity 38
CAS# NA
M.F.: C14H13NO6
M.W.: 291.26 |
|
|
| QI200337 |
Irinotecan Impurity 37
CAS# 1806485-04-0
M.F.: C9H8FNO3
M.W.: 197.16 |
|
|
| QD182400 |
Droxidopa
CAS# 23651-95-8
M.F.: C9H11NO5
M.W.: 213.19 |
|
|
| QD182403 |
Droxidopa Impurity 3
CAS# 34047-62-6
M.F.: C9H11NO5
M.W.: 213.19 |
|
|
| QD182402 |
Droxidopa Impurity 2
CAS# 51829-99-3
M.F.: C9H11NO5
M.W.: 213.19 |
|
|
| QD182401 |
Droxidopa Impurity 1
CAS# 51829-98-2
M.F.: C9H11NO5
M.W.: 213.19 |
|
|
| QV041413 |
Hydroxy Vardenafil
CAS# 224785-98-2
M.F.: C23H32N6O5S
M.W.: 504.60 |
|
|
| QC-D052001 |
methyl 3-oxo-2,4-diphenylbutanoate
CAS# 40195-49-1
M.F.: C17H16O3
M.W.: 268.31 |
|
|
| QC-D090213 |
1,2-dibromoethane
CAS# 106-93-4
M.F.: C2H4Br2
M.W.: 187.86 |
|
|
| QG140938 |
Ganciclovir Impurity 38
CAS# 1356932-18-7
M.F.: C14H22N6O5
M.W.: 354.36 |
|
|
| QC-O241509 |
2-oxoacetamide
CAS# 60939-21-1
M.F.: C2H3NO2
M.W.: 73.05 |
|
|
| QC-D091379 |
N,N-dimethyl-2-oxoacetamide
CAS# 79036-50-3
M.F.: C4H7NO2
M.W.: 101.1 |
|
|
| QB180947 |
Brivaracetam Impurity 21
CAS# NA
M.F.: C20H31NO4
M.W.: 349.46 |
|
|
| QB180946 |
Brivaracetam Impurity 20
CAS# 81381-87-5
M.F.: C7H14O3
M.W.: 146.18 |
|
|
| QB180945 |
Brivaracetam Impurity 19
CAS# 861567-92-2
M.F.: C7H14Br2
M.W.: 257.99 |
|
|
| QB180944 |
Brivaracetam Impurity 18
CAS# 2200297-71-6
M.F.: C11H21BrO2
M.W.: 265.19 |
|
|
| QB180943 |
Brivaracetam Impurity 17
CAS# 2167633-39-6
M.F.: C9H18O3
M.W.: 174.24 |
|
|
| QB180942 |
Brivaracetam Impurity 16
CAS# 2432911-31-2
M.F.: C11H18N2O3
M.W.: 226.27 |
|
|
| QP090313 |
Picosulfate Impurity 13
CAS# 2379877-99-1
M.F.: C18H15NO3
M.W.: 293.32 |
|
|
| QP090312 |
Picosulfate Impurity 12
CAS# 16985-07-2
M.F.: C18H15NO2
M.W.: 277.32 |
|
|
| QP090311 |
Picosulfate Impurity 11
CAS# NA
M.F.: C18H15NO3
M.W.: 293.32 |
|
|
| QP090310 |
Picosulfate Impurity 10
CAS# 26838-86-8
M.F.: C12H9NO2
M.W.: 199.21 |
|
|
| QP090309 |
Picosulfate Impurity 9
CAS# 109810-81-3
M.F.: C18H15NO2
M.W.: 277.32 |
|
|
| QP090308 |
Picosulfate Impurity 8
CAS# 13004-51-8
M.F.: C18H15NO2
M.W.: 277.32 |
|
|
| QI132058 |
Imatinib Impurity 58
CAS# 1802325-93-4
M.F.: C20H22N2O4
M.W.: 354.40 |
|
|
| QE182046 |
Erythromycin A 9-Oxime (Mixture of Z and E Isomers)
CAS# 13127-18-9
M.F.: C37H68N2O13
M.W.: 748.94 |
|
|
| QD050400 |
Dehydrocholic acid
CAS# 81-23-2
M.F.: C24H34O5
M.W.: 402.52 |
|
|
| QC-A130990 |
(1-aminoethyl)phosphinic acid
CAS# 74333-44-1
M.F.: C2H8NO2P
M.W.: 109.06 |
|
|
| QV1416106 |
Vonoprazan Impurity 106
CAS# NA
M.F.: C17H18FN3O2S
M.W.: 347.41 |
|
|
| QZ161831 |
Ziprasidone Impurity 31
CAS# 510703-85-2
M.F.: C10H10ClNO2
M.W.: 211.64 |
|
|
| QZ161828 |
Ziprasidone Impurity 28
CAS# NA
M.F.: C10H9Cl2NO
M.W.: 230.09 |
|
|
| QZ161827 |
Ziprasidone Impurity 27
CAS# NA
M.F.: C10H7Cl2NO2
M.W.: 244.07 |
|
|
| QC-P091608 |
N1-(2-(piperazin-1-yl)ethyl)ethane-1,2-diamine
CAS# 24028-46-4
M.F.: C8H20N4
M.W.: 172.27 |
|
|
| QK201836 |
(R)-Ketorolac
CAS# 66635-93-6
M.F.: C15H13NO3
M.W.: 255.27 |
|
|
| QE161243 |
Epalrestat Impurity 17
CAS# 130786-32-2
M.F.: C8H9NO3S2
M.W.: 231.29 |
|
|
| QE161242 |
Epalrestat Impurity 16
CAS# 1151944-57-8
M.F.: C12H9NO3S2
M.W.: 279.33 |
|
|
| QM010600 |
Mafosfamide Sodium Salt
CAS# 84211-05-2
M.F.: C9H18Cl2N2NaO5PS2
M.W.: 423.25 |
|
|
| QC022024 |
Cabazitaxel Impurity 24
CAS# NA
M.F.: C58H72N2O18
M.W.: 1085.19 |
|
|
| QC022023 |
Cabazitaxel Impurity 23
CAS# NA
M.F.: C44H55NO14
M.W.: 821.91 |
|
|
| QC022022 |
Cabazitaxel Impurity 22
CAS# NA
M.F.: C44H55NO14
M.W.: 821.91 |
|
|
| QC022021 |
Cabazitaxel Impurity 21
CAS# NA
M.F.: C43H59NO14
M.W.: 813.93 |
|
|
| QC022020 |
Cabazitaxel Impurity 20
CAS# NA
M.F.: C45H57NO14
M.W.: 835.93 |
|
|
| QC022019 |
Cabazitaxel Impurity 19
CAS# NA
M.F.: C40H49NO12
M.W.: 735.82 |
|
|
| QC022018 |
Cabazitaxel Impurity 18
CAS# NA
M.F.: C53H63NO15
M.W.: 954.07 |
|
|
| QC022017 |
Cabazitaxel Impurity 17
CAS# NA
M.F.: C58H72N2O18
M.W.: 1085.19 |
|
|
| QO192066 |
Oseltamivir Impurity 66
CAS# NA
M.F.: C22H34N2O10
M.W.: 486.51 |
|
|
| QO192065 |
Oseltamivir Impurity 65
CAS# NA
M.F.: C22H34N2O10
M.W.: 486.51 |
|
|
| QI132057 |
Imatinib Impurity 57
CAS# NA
M.F.: C18H17N5O
M.W.: 319.36 |
|
|
| QI132056 |
Imatinib Impurity 56
CAS# NA
M.F.: C9H13N5O
M.W.: 207.23 |
|
|
| QI132055 |
Imatinib Impurity 55
CAS# NA
M.F.: C9H14N6
M.W.: 206.25 |
|
|
| QI132054 |
Imatinib Impurity 54
CAS# NA
M.F.: C9H11N5O3
M.W.: 237.22 |
|
|
| QC-N092033 |
2-ethyl-5-nitroaniline
CAS# 20191-74-6
M.F.: C8H10N2O2
M.W.: 166.18 |
|
|
| QI201512 |
Itopride Impurity L
CAS# NA
M.F.: C28H32N2O7
M.W.: 508.56 |
|
|
| QI201511 |
Itopride Impurity K
CAS# 3943-77-9
M.F.: C11H14O4
M.W.: 210.23 |
|
|
| QI201510 |
Itopride Impurity J
CAS# NA
M.F.: C20H26N2O5
M.W.: 374.43 |
|
|
| QV031306 |
Vancomycin CDP-1
CAS# 55598-85-1
M.F.: C66H74Cl2N8O25
M.W.: 1450.24 |
|
|
| QC161322 |
Cefepime dimer
CAS# NA
M.F.: C33H37N11O10S4
M.W.: 875.97 |
|
|
| QC-H052414 |
(S)-4-chloro-3-hydroxybutanenitrile
CAS# 127913-44-4
M.F.: C4H6ClNO
M.W.: 119.55 |
|
|
| QC-H052413 |
3-hydroxypentanedinitrile
CAS# 13880-89-2
M.F.: C5H6N2O
M.W.: 110.11 |
|
|
| QC-H052412 |
2-hydroxy-N1,N1,N1,N3,N3,N3-hexamethylpropane-1,3-diaminium chloride
CAS# 55636-09-4
M.F.: C9H24Cl2N2O
M.W.: 247.21 |
|
|
| QC-H250487 |
sodium 2-hydroxypropanoate
CAS# 72-17-3
M.F.: C3H5NaO3
M.W.: 112.06 |
|
|
| QD032053 |
Docetaxel Impurity 53
CAS# NA
M.F.: C43H51NO15
M.W.: 821.86 |
|
|
| QD032052 |
Docetaxel Impurity 52
CAS# NA
M.F.: C43H49NO15
M.W.: 819.85 |
|
|
| QD032051 |
Docetaxel Impurity 51
CAS# NA
M.F.: C43H53NO15
M.W.: 823.88 |
|
|
| QT180671 |
Tirofiban Impurity 71
CAS# NA
M.F.: C22H35ClN2O5S HCl
M.W.: 475.04 36.46 |
|
|
| QT180670 |
Tirofiban Impurity 70
CAS# 109315-44-8
M.F.: C9H12BrN
M.W.: 214.10 |
|
|
| QC-P051408 |
4-pentylpyridine
CAS# 2961-50-4
M.F.: C10H15N
M.W.: 149.23 |
|
|
| QC-T180976 |
2,2,2-trifluoroacetamide
CAS# 354-38-1
M.F.: C2H2F3NO
M.W.: 113.04 |
|
|
| QT180669 |
Tirofiban Impurity 69
CAS# 25561-30-2
M.F.: C8H18F3NOSi2
M.W.: 257.40 |
|
|
| QW090800 |
Withanone
CAS# 27570-38-3
M.F.: C28H38O6
M.W.: 470.60 |
|
|
| QP132074 |
Pemetrexed Impurity 48
CAS# NA
M.F.: C15H16N4O3
M.W.: 300.31 |
|
|
| QC-D091378 |
5-(dimethylamino)naphthalene-1-sulfonyl chloride
CAS# 605-65-2
M.F.: C12H12ClNO2S
M.W.: 269.75 |
|
|
| QC-M050889 |
2-(4-methylpyrimidin-2-yl)cyclopropanecarboxylic acid
CAS# NA
M.F.: C9H10N2O2
M.W.: 178.19 |
|
|
| QE201934 |
Desethyl Sacubitril-d4
CAS# NA
M.F.: C22H21D4NO5
M.W.: 387.46 |
|
|
| QF122031 |
Fluticasone Impurity 31
CAS# 397864-41-4
M.F.: C31H30F2O8S
M.W.: 600.63 |
|
|
| QC-D090829 |
sodium (2R,3R)-2,3-dihydroxysuccinate
CAS# 868-18-8
M.F.: C4H4Na2O6
M.W.: 194.05 |
|
|
| QP1903107 |
Posaconazole Impurity 107
CAS# 183871-36-5
M.F.: C12H20N2O C18H14O8
M.W.: 208.30 358.30 |
|
|
| QC-D090343 |
2-(2,6-dichlorophenyl)-N-(N-hydroxycarbamimidoyl)acetamide
CAS# 199658-79-2
M.F.: C9H9Cl2N3O2
M.W.: 262.09 |
|
|
| QS010259 |
Salbutamol Impurity 33
CAS# NA
M.F.: C16H25NO3
M.W.: 279.37 |
|
|
| QC-C081546 |
3-(chloromethyl)benzonitrile
CAS# 64407-07-4
M.F.: C8H6ClN
M.W.: 151.59 |
|
|
| QC-C081545 |
2-(chloromethyl)benzonitrile
CAS# 612-13-5
M.F.: C8H6ClN
M.W.: 151.59 |
|
|
| QC-M050888 |
4-methylbenzene-1,3-diamine
CAS# 95-80-7
M.F.: C7H10N2
M.W.: 122.17 |
|
|
| QC-M050887 |
4-methyl-3-nitroaniline
CAS# 119-32-4
M.F.: C7H8N2O2
M.W.: 152.15 |
|
|
| QC-M050886 |
2-methyl-3-nitroaniline
CAS# 603-83-8
M.F.: C7H8N2O2
M.W.: 152.15 |
|
|
| QI132053 |
Imatinib Impurity 53
CAS# 1356565-46-2
M.F.: C42H47N9O2
M.W.: 709.88 |
|
|
| QC012401 |
N-Caproylsphingosine
CAS# 124753-97-5
M.F.: C24H47NO3
M.W.: 397.63 |
|
|
| QP161628 |
Propafenone Impurity 28
CAS# 93885-22-4
M.F.: C21H27NO4 HCl
M.W.: 357.44 36.46 |
|
|
| QI151617 |
Iopamidol Impurity 17
CAS# NA
M.F.: C10H9NO4
M.W.: 207.18 |
|
|
| QP161627 |
Propafenone Impurity 27
CAS# NA
M.F.: C18H16D5NO3
M.W.: 304.40 |
|
|
| QP161626 |
Propafenone Impurity 26
CAS# NA
M.F.: C21H22D5NO3
M.W.: 346.47 |
|
|
| QP161625 |
Propafenone Impurity 25
CAS# NA
M.F.: C27H35NO9
M.W.: 517.57 |
|
|
| QP161624 |
Despropyl propafenone-d5
CAS# NA
M.F.: C18H16D5NO3
M.W.: 304.40 |
|
|
| QP161623 |
5-Hydroxy Propafenone-d5
CAS# 1188265-48-6(HCl salt)
M.F.: C21H22D5NO4
M.W.: 362.47 |
|
|
| QP161622 |
Propafenone Impurity 22
CAS# NA
M.F.: C21H27NO3
M.W.: 341.44 |
|
|
| QP161621 |
Propafenone-d5
CAS# NA
M.F.: C21H22D5NO3
M.W.: 346.47 |
|
|
| QP161620 |
(S)-Propafenone
CAS# 107381-32-8
M.F.: C21H27NO3
M.W.: 341.44 |
|
|
| QP161619 |
(R)-Propafenone
CAS# 107381-31-7
M.F.: C21H27NO3
M.W.: 341.44 |
|
|
| QP161618 |
Propafenone Impurity 18
CAS# NA
M.F.: C21H27NO4
M.W.: 357.44 |
|
|
| QP161617 |
Propafenone Impurity 17
CAS# 16298-38-7
M.F.: C21H30N2
M.W.: 310.48 |
|
|
| QP161616 |
Propafenone Impurity 16
CAS# NA
M.F.: C22H27NO4
M.W.: 369.45 |
|
|
| QP161615 |
Propafenone Impurity 15
CAS# NA
M.F.: C24H31N3O7
M.W.: 473.52 |
|
|
| QP161614 |
Propafenone Impurity 14
CAS# NA
M.F.: C29H46N2
M.W.: 422.69 |
|
|
| QP161613 |
Propafenone Impurity 13
CAS# 1188263-52-6
M.F.: C18H21NO3 HCl
M.W.: 299.36 36.46 |
|
|
| QP161612 |
Propafenone Impurity 12
CAS# 1346598-57-9
M.F.: C21H27NO7S
M.W.: 437.51 |
|
|
| QP161611 |
Propafenone Impurity 11
CAS# NA
M.F.: C27H35NO10
M.W.: 533.57 |
|
|
| QE161241 |
Epalrestat Impurity 15
CAS# 31061-24-2
M.F.: C5H5NO4S
M.W.: 175.16 |
|
|
| QP1903106 |
Posaconazole Impurity 106
CAS# 175712-02-4
M.F.: C20H18ClF2N3O4S
M.W.: 469.89 |
|
|
| QC-D090342 |
ethyl 2-(2,6-dichlorophenyl)acetate
CAS# 90793-64-9
M.F.: C10H10Cl2O2
M.W.: 233.09 |
|
|
| QC-D090341 |
N-carbamoyl-2-(2,6-dichlorophenyl)acetamide
CAS# 78622-22-7
M.F.: C9H8Cl2N2O2
M.W.: 247.08 |
|
|
| QC-D090340 |
2-(2,6-dichlorophenyl)acetamide
CAS# 78433-88-2
M.F.: C8H7Cl2NO
M.W.: 204.05 |
|
|
| QC-D090339 |
methyl 2-(2,6-dichlorophenyl)acetate
CAS# 54551-83-6
M.F.: C9H8Cl2O2
M.W.: 219.06 |
|
|
| QC-D090338 |
2-(2,6-dichlorophenyl)acetic acid
CAS# 6575-24-2
M.F.: C8H6Cl2O2
M.W.: 205.04 |
|
|
| QP181918 |
Prasugrel Impurity R
CAS# 239466-74-1
M.F.: C18H20FNO3S
M.W.: 349.42 |
|
|
| QS132248 |
Simvastatin Impurity 48
CAS# 149949-05-3
M.F.: C25H38O6
M.W.: 434.57 |
|
|
| QC-T180975 |
2,4,6-trimethoxyphenol
CAS# 20491-92-3
M.F.: C9H12O4
M.W.: 184.19 |
|
|
| QC-H052411 |
2,2',4,4',6,6'-hexabromo-1,1'-biphenyl
CAS# 59261-08-4
M.F.: C12H4Br6
M.W.: 627.58 |
|
|
| QP160620 |
4-Hydroxy Propofol
CAS# 1988-10-9
M.F.: C12H18O2
M.W.: 194.27 |
|
|
| QT260224 |
Tazobactam Impurity X
CAS# 117030-11-2
M.F.: C8H10N4O5S
M.W.: 274.25 |
|
|
| QT260223 |
Tazobactam Impurity W
CAS# 89051-57-0
M.F.: C8H10N4O3S
M.W.: 242.26 |
|
|
| QT260222 |
Tazobactam Impurity V
CAS# 95835-17-9
M.F.: C8H10ClNO3S
M.W.: 235.69 |
|
|
| QT260221 |
Tazobactam Impurity U
CAS# 89051-49-0
M.F.: C21H20N4O5S
M.W.: 440.47 |
|
|
| QN031850 |
Nicorandil Impurity 24
CAS# NA
M.F.: C16H19IN4O3
M.W.: 442.25 |
|
|
| QU190432 |
Ursodeoxycholic Acid Impurity 32
CAS# 108179-87-9
M.F.: C24H40O5
M.W.: 408.57 |
|
|
| QU190431 |
Ursodeoxycholic Acid Impurity 31
CAS# 80434-32-8
M.F.: C24H40O5
M.W.: 408.57 |
|
|
| QU190430 |
Ursodeoxycholic Acid Impurity 30
CAS# 2393-59-1
M.F.: C24H40O5
M.W.: 408.57 |
|
|
| QU190429 |
Ursodeoxycholic Acid Impurity 29
CAS# 2393-58-0
M.F.: C24H40O5
M.W.: 408.57 |
|
|
| QU190428 |
Ursodeoxycholic Acid Impurity 28
CAS# 6830-03-1
M.F.: C24H40O5
M.W.: 408.57 |
|
|
| QU190427 |
Ursodeoxycholic Acid Impurity 27
CAS# 3338-16-7
M.F.: C24H40O5
M.W.: 408.57 |
|
|
| QU190426 |
Ursodeoxycholic Acid Impurity 26
CAS# 570-62-7
M.F.: C24H40O4
M.W.: 392.57 |
|
|
| QC080302 |
Cholic Acid Impurity 2
CAS# 566-24-5
M.F.: C24H40O4
M.W.: 392.57 |
|
|
| QC080301 |
Cholic Acid Impurity 1
CAS# 89238-74-4
M.F.: C24H40O4
M.W.: 392.57 |
|
|
| QI190900 |
Isolithocholic Acid
CAS# 1534-35-6
M.F.: C24H40O3
M.W.: 376.57 |
|
|
| QC022645 |
Cabozantinib Impurity 45
CAS# NA
M.F.: C28H24FN3O5
M.W.: 501.51 |
|
|
| QC022644 |
Cabozantinib Impurity 44
CAS# NA
M.F.: C28H24FN3O5
M.W.: 501.51 |
|
|
| QC022643 |
Cabozantinib Impurity 43
CAS# 1677-29-8
M.F.: C15H12F2N2O2
M.W.: 290.26 |
|
|
| QC022642 |
Cabozantinib Impurity 42
CAS# 95262-10-5
M.F.: C9H8FNO3
M.W.: 197.16 |
|
|
| QC022641 |
Cabozantinib Impurity 41
CAS# NA
M.F.: C12H12FNO3
M.W.: 237.23 |
|
|
| QC022640 |
Cabozantinib Impurity 40
CAS# NA
M.F.: C11H11ClFNO3
M.W.: 259.66 |
|
|
| QC022639 |
Cabozantinib Impurity 39
CAS# NA
M.F.: C9H15ClO4
M.W.: 222.67 |
|
|
| QC022638 |
Cabozantinib Impurity 38
CAS# NA
M.F.: C28H25ClFN3O5
M.W.: 537.97 |
|
|
| QC022637 |
Cabozantinib Impurity 37
CAS# NA
M.F.: C28H25N3O5
M.W.: 483.52 |
|
|
| QC022636 |
Cabozantinib Impurity 36
CAS# NA
M.F.: C18H16F2N2O2
M.W.: 330.33 |
|
|
| QC022635 |
Cabozantinib Impurity 35
CAS# NA
M.F.: C18H18N2O2
M.W.: 294.35 |
|
|
| QC022634 |
Cabozantinib Impurity 34
CAS# NA
M.F.: C17H16N2O3
M.W.: 296.32 |
|
|
| QC022633 |
Cabozantinib Impurity 33
CAS# NA
M.F.: C23H22N2O6
M.W.: 422.43 |
|
|
| QC022632 |
Cabozantinib Impurity 32
CAS# NA
M.F.: C29H27N3O5
M.W.: 497.54 |
|
|
| QC022631 |
Cabozantinib Impurity 31
CAS# NA
M.F.: C12H13NO3
M.W.: 219.24 |
|
|
| QC022629 |
Cabozantinib Impurity 29
CAS# NA
M.F.: C11H15NO3
M.W.: 209.24 |
|
|
| QP070402 |
PGE-M
CAS# 24769-56-0
M.F.: C16H24O7
M.W.: 328.36 |
|
|
| QP070401 |
PGD-M
CAS# 133161-96-3
M.F.: C16H24O7
M.W.: 328.36 |
|
|
| QL051101 |
Leukotriene E4
CAS# 75715-89-8
M.F.: C23H37NO5S
M.W.: 439.61 |
|
|
| QC-T180974 |
N,N,N-trimethyl-1-phenylmethanaminium chloride
CAS# 56-93-9
M.F.: C10H16ClN
M.W.: 185.69 |
|
|
| QT0603141 |
Tofacitinib Impurity 141
CAS# NA
M.F.: C10H14N2O4
M.W.: 226.23 |
|
|
| QT0603140 |
Tofacitinib Impurity 140
CAS# NA
M.F.: C13H19N5
M.W.: 245.32 |
|
|
| QT0603139 |
Tofacitinib Impurity 139
CAS# NA
M.F.: C13H19N5
M.W.: 245.32 |
|
|
| QT150301 |
D-alpha-Tocopherylquinone
CAS# 7559-04-8
M.F.: C29H50O3
M.W.: 446.71 |
|
|
| QE201933 |
Sacubitril Impurity 33
CAS# NA
M.F.: C25H33NO5
M.W.: 427.53 |
|
|
| QO181444 |
Ornidazole Impurity 44
CAS# 1064004-83-6
M.F.: C7H11N3O4
M.W.: 201.18 |
|
|
| QC-B181552 |
4-bromobutanoic acid
CAS# 2623-87-2
M.F.: C4H7BrO2
M.W.: 167.00 |
|
|
| QC-E082501 |
ethyl 4-bromobutanoate
CAS# 2969-81-5
M.F.: C6H11BrO2
M.W.: 195.05 |
|
|
| QA182612 |
Arginine glutamate
CAS# 4320-30-3
M.F.: C5H9NO4 C6H14N4O2
M.W.: 147.13 174.20 |
|
|
| QS212500 |
Suxamethonium chloride
CAS# 6101-15-1
M.F.: C14H34Cl2N2O6
M.W.: 397.34 |
|
|
| QE200243 |
(E)-Eltrombopag
CAS# NA
M.F.: C25H22N4O4
M.W.: 442.47 |
|
|
| QV307761 |
Vitamin B6 Impurity 61
CAS# 58947-70-9
M.F.: C8H9NO3
M.W.: 167.16 |
|
|
| QC-I191529 |
3-isopropyl-8-methyl-1,5-dihydro-[1,3]dioxepino[5,6-c]pyridin-9-ol
CAS# 1622-67-9
M.F.: C12H17NO3
M.W.: 223.27 |
|
|
| QC-P181538 |
2-propyl-4,7-dihydro-1,3-dioxepine
CAS# 4469-34-5
M.F.: C8H14O2
M.W.: 142.20 |
|
|
| QC-E200899 |
5-ethoxy-4-methyloxazole
CAS# 5006-20-2
M.F.: C6H9NO2
M.W.: 127.14 |
|
|
| QI192232 |
Isavuconazole Impuirty 32
CAS# NA
M.F.: C40H43F2IN8O7S
M.W.: 944.79 |
|
|
| QI192231 |
Isavuconazole Impuirty 31
CAS# NA
M.F.: C32H31F2N7O8S2
M.W.: 743.76 |
|
|
| QI192230 |
Isavuconazole Impuirty 30
CAS# NA
M.F.: C49H53F2N11O15S2
M.W.: 1138.14 |
|
|
| QI192229 |
Isavuconazole Impuirty 29
CAS# NA
M.F.: C39H46F2N8O10S2
M.W.: 888.96 |
|
|
| QI192228 |
Isavuconazole Impuirty 28
CAS# NA
M.F.: C37H40F2N8O10S2
M.W.: 858.89 |
|
|
| QI192227 |
Isavuconazole Impuirty 27
CAS# NA
M.F.: C35H36F2N8O9S2
M.W.: 814.84 |
|
|
| QI192226 |
Isavuconazole Impuirty 26
CAS# NA
M.F.: C29H36F2N8O9S2
M.W.: 742.77 |
|
|
| QI192225 |
Isavuconazole Impuirty 25
CAS# NA
M.F.: C35H38F2N8O10S2
M.W.: 832.85 |
|
|
| QI192224 |
Isavuconazole Impuirty 24
CAS# NA
M.F.: C8H8N2O2
M.W.: 164.16 |
|
|
| QI220245 |
Ivabradine Impurity 45
CAS# 1192174-72-3
M.F.: C15H20BrNO3
M.W.: 342.23 |
|
|
| QI220244 |
Ivabradine Impurity 44
CAS# 1192174-73-4
M.F.: C15H20INO3
M.W.: 389.23 |
|
|
| QI220243 |
Ivabradine Impurity 43
CAS# 1279201-09-0
M.F.: C15H22INO2
M.W.: 375.25 |
|
|
| QI220242 |
Ivabradine Impurity 42
CAS# 1031767-71-1
M.F.: C15H22ClNO2
M.W.: 283.79 |
|
|
| QI220241 |
Ivabradine Impurity 41
CAS# 1279201-07-8
M.F.: C15H22BrNO2
M.W.: 328.24 |
|
|
| QI151616 |
Iopamidol Impurity 16
CAS# NA
M.F.: C14H19N3O8
M.W.: 357.32 |
|
|
| QP180780 |
Pregabalin Impurity 80
CAS# NA
M.F.: C8H13NO2
M.W.: 155.19 |
|
|
| QS201600 |
Stepholidine
CAS# 16562-13-3
M.F.: C19H21NO4
M.W.: 327.37 |
|
|
| QS120726 |
Saxagliptin Impurity 26
CAS# NA
M.F.: C18H23N3O2 HCl
M.W.: 313.39 36.46 |
|
|
| QN200413 |
Nitrendipine Impurity 13
CAS# NA
M.F.: C18H20N2O6
M.W.: 360.36 |
|
|
| QL252018 |
Lysine Impurity 18
CAS# NA
M.F.: C12H26N4O3
M.W.: 274.36 |
|
|
| QL252017 |
Lysine Impurity 17
CAS# 164262-23-1
M.F.: C12H26N4O3 3HCl
M.W.: 274.36 109.38 |
|
|
| QL252016 |
Lysine Impurity 16
CAS# NA
M.F.: C6H14N2O3
M.W.: 162.19 |
|
|
| QL252015 |
Lysine Impurity 15
CAS# 19460-99-2
M.F.: C6H14N2O3
M.W.: 162.19 |
|
|
| QP020364 |
Palbociclib Impurity 64
CAS# NA
M.F.: C36H49N7O12
M.W.: 771.81 |
|
|
| QP020363 |
Palbociclib Impurity 63
CAS# NA
M.F.: C36H49N7O12
M.W.: 771.81 |
|
|
| QA070281 |
Argatroban Impurity 55
CAS# NA
M.F.: C27H43N5O7S
M.W.: 581.72 |
|
|
| QA070280 |
Argatroban Impurity 54
CAS# NA
M.F.: C26H41N5O5S
M.W.: 535.70 |
|
|
| QA070279 |
Argatroban Impurity 53
CAS# NA
M.F.: C13H19NO5S
M.W.: 301.36 |
|
|
| QI220240 |
Ivabradine Impurity 40
CAS# 1220993-44-1
M.F.: C11H12O4
M.W.: 208.21 |
|
|
| QC-E200898 |
ethyl 4-(chloromethyl)benzoate
CAS# 1201-90-7
M.F.: C10H11ClO2
M.W.: 198.65 |
|
|
| QD151619 |
Dopamine Impurity 19
CAS# NA
M.F.: C10H14ClNO2 HCl
M.W.: 215.68 36.46 |
|
|
| QA261226 |
Azelastine Impurity 26
CAS# 956-07-0
M.F.: C14H12N2O
M.W.: 224.26 |
|
|
| QA261225 |
Azelastine Impurity 25
CAS# 105279-24-1
M.F.: C15H9ClO2
M.W.: 256.68 |
|
|
| QC-M050885 |
methyl 2-amino-3-hydroxypropanoate
CAS# 2104-89-4
M.F.: C4H9NO3
M.W.: 119.12 |
|
|
| QR141218 |
Ranolazine Impurity R
CAS# NA
M.F.: C18H23NO3
M.W.: 301.38 |
|
|
| QR141217 |
Ranolazine Impurity Q
CAS# NA
M.F.: C18H23NO3
M.W.: 301.38 |
|
|
| QR141216 |
Ranolazine Impurity P
CAS# NA
M.F.: C18H22N2O
M.W.: 282.38 |
|
|
| QR141215 |
Ranolazine Impurity O
CAS# 2050-43-3
M.F.: C10H13NO
M.W.: 163.22 |
|
|
| QR141214 |
Ranolazine Impurity N
CAS# NA
M.F.: C10H13NO2
M.W.: 179.22 |
|
|
| QR141213 |
Ranolazine Impurity M
CAS# 29183-14-0
M.F.: C10H13NO2
M.W.: 179.22 |
|
|
| QR141212 |
Ranolazine Impurity L
CAS# 2851-82-3
M.F.: C12H14O4
M.W.: 222.24 |
|
|
| QC-D091377 |
2,4-dimethylaniline
CAS# 95-68-1
M.F.: C8H11N
M.W.: 121.18 |
|
|
| QP181671 |
Pramipexole Impurity 71
CAS# NA
M.F.: C8H11NO2
M.W.: 153.18 |
|
|
| QP181670 |
Pramipexole Impurity 70
CAS# NA
M.F.: C8H13NO3
M.W.: 171.19 |
|
|
| QC-D091376 |
2,4-dimethyl-1-nitrobenzene
CAS# 89-87-2
M.F.: C8H9NO2
M.W.: 151.16 |
|
|
| QC-D091375 |
1,3-dimethyl-2-nitrobenzene
CAS# 81-20-9
M.F.: C8H9NO2
M.W.: 151.16 |
|
|
| QX620501 |
m-xylene
CAS# 108-38-3
M.F.: C8H10
M.W.: 106.16 |
|
|
| QC-E200897 |
ethyl hydrogen sulfate
CAS# 540-82-9
M.F.: C2H6O4S
M.W.: 126.13 |
|
|
| QC-D090212 |
1,3-dibromopropane
CAS# 109-64-8
M.F.: C3H6Br2
M.W.: 201.89 |
|
|
| QC-D090211 |
1,2-dibromopropane
CAS# 78-75-1
M.F.: C3H6Br2
M.W.: 201.89 |
|
|
| QC-D091374 |
2,2-dimethoxyethanamine
CAS# 22483-09-6
M.F.: C4H11NO2
M.W.: 105.14 |
|
|
| QF051803 |
Ferulic acid Impurity 3
CAS# 4475-29-0
M.F.: C11H10O6
M.W.: 238.19 |
|
|
| QE200242 |
Eltrombopag Impurity 16
CAS# NA
M.F.: C13H8N2O3
M.W.: 240.21 |
|
|
| QF051802 |
trans-Ferulic acid
CAS# 537-98-4
M.F.: C10H10O4
M.W.: 194.18 |
|
|
| QF051801 |
Ferulic acid (cis)
CAS# 1014-83-1
M.F.: C10H10O4
M.W.: 194.18 |
|
|
| QT151505 |
Tolnaftate Impurity 5
CAS# 842-07-9
M.F.: C16H12N2O
M.W.: 248.28 |
|
|
| QA030320 |
Acetylcysteine Impurity 20
CAS# 103974-29-4
M.F.: C7H12N2O4S
M.W.: 220.25 |
|
|
| QP1903105 |
Posaconazole Impurity 105
CAS# NA
M.F.: C74H81F2N13O7
M.W.: 1302.51 |
|
|
| QC-E200896 |
ethyl acetate
CAS# 141-78-6
M.F.: C4H8O2
M.W.: 88.11 |
|
|
| QC-H052410 |
hexane
CAS# 110-54-3
M.F.: C6H14
M.W.: 86.18 |
|
|
| QB131624 |
Bimatoprost Impurity X
CAS# NA
M.F.: C27H41NO4
M.W.: 443.62 |
|
|
| QB131623 |
Bimatoprost Impurity W
CAS# NA
M.F.: C29H43NO4
M.W.: 469.66 |
|
|
| QB131622 |
Bimatoprost Impurity V
CAS# 1163135-95-2
M.F.: C25H37NO4
M.W.: 415.57 |
|
|
| QB131621 |
Bimatoprost Impurity U
CAS# 38315-47-8
M.F.: C24H34O5
M.W.: 402.52 |
|
|
| QB131620 |
Bimatoprost Impurity T
CAS# 1163135-96-3
M.F.: C25H35NO4
M.W.: 413.55 |
|
|
| QB131619 |
Bimatoprost Impurity S
CAS# NA
M.F.: C25H36O5
M.W.: 416.55 |
|
|
| QB131618 |
Bimatoprost Impurity R
CAS# NA
M.F.: C18H26O4
M.W.: 306.40 |
|
|
| QB131617 |
Bimatoprost Impurity Q
CAS# 856240-62-5
M.F.: C18H24O4
M.W.: 304.38 |
|
|
| QB131616 |
5-trans Bimatoprost-d5
CAS# 1163135-95-2 (non-labelled)
M.F.: C25H32D5NO4
M.W.: 420.60 |
|
|
| QB131615 |
Bimatoprost Impurity O
CAS# NA
M.F.: C35H53NO6
M.W.: 583.80 |
|
|
| QB131614 |
Bimatoprost Impurity N
CAS# NA
M.F.: C35H51NO6
M.W.: 581.78 |
|
|
| QB131613 |
Bimatoprost Impurity M
CAS# 41162-19-0
M.F.: C12H17O4P
M.W.: 256.23 |
|
|
| QB131612 |
Bimatoprost-d5
CAS# 420.60
M.F.: C25H32D5NO4
M.W.: 420.60 |
|
|
| QB131611 |
Bimatoprost Impurity K
CAS# NA
M.F.: C25H41NO6
M.W.: 451.60 |
|
|
| QB131610 |
Bimatoprost Impurity J
CAS# NA
M.F.: C25H43NO6
M.W.: 453.61 |
|
|
| QB131609 |
Bimatoprost Impurity I
CAS# NA
M.F.: C34H63NO6Si
M.W.: 609.95 |
|
|
| QB131608 |
Bimatoprost Impurity H
CAS# 76704-05-7
M.F.: C8H12O4
M.W.: 172.18 |
|
|
| QB131607 |
Bimatoprost Impurity G
CAS# 1201226-16-5
M.F.: C25H29BrNOP
M.W.: 470.38 |
|
|
| QB131606 |
Bimatoprost Impurity F
CAS# 41639-71-8
M.F.: C23H32O5
M.W.: 388.50 |
|
|
| QB131605 |
Bimatoprost Impurity E
CAS# 155206-01-2
M.F.: C24H35NO4
M.W.: 401.54 |
|
|
| QB131604 |
Bimatoprost Impurity D
CAS# NA
M.F.: C23H30O4
M.W.: 370.48 |
|
|
| QB131603 |
Bimatoprost Impurity C
CAS# NA
M.F.: C23H33NO4
M.W.: 387.51 |
|
|
| QB131602 |
Bimatoprost Impurity B
CAS# NA
M.F.: C25H37NO5
M.W.: 431.56 |
|
|
| QB131601 |
Bimatoprost
CAS# 155206-00-1
M.F.: C25H37NO4
M.W.: 415.57 |
|
|
| QB131628 |
Bimatoprost Impurity 2
CAS# 41639-74-1
M.F.: C18H22O4
M.W.: 302.36 |
|
|
| QS180625 |
Sorafenib tosylate Impurity Y
CAS# 2204442-52-2
M.F.: C27H23N5O6
M.W.: 513.50 |
|
|
| QP1824106 |
Parecoxib Sodium Impurity 80
CAS# 198470-82-5
M.F.: C20H20N2O4S
M.W.: 384.45 |
|
|
| QE062232 |
Efavirenz Impurity 32
CAS# 1627575-36-3
M.F.: C14H11ClF3NO2
M.W.: 317.69 |
|
|
| QE062231 |
Efavirenz Impurity 31 (Mixture of Z and E Isomers)
CAS# 2125704-30-3
M.F.: C14H9ClF3NO2
M.W.: 315.67 |
|
|
| QL050325 |
Lercanidipine Impurity 25
CAS# NA
M.F.: C23H35NOSi
M.W.: 369.62 |
|
|
| QC-H250486 |
2-(2-hydroxyethyl)benzene-1,3,5-triol
CAS# 2228757-11-5
M.F.: C8H10O4
M.W.: 170.16 |
|
|
| QC-H250485 |
2-(1-hydroxyethyl)benzene-1,3,5-triol
CAS# 1132751-79-1
M.F.: C8H10O4
M.W.: 170.16 |
|
|
| QT180668 |
Tirofiban Impurity 68
CAS# NA
M.F.: C31H53N3O5S
M.W.: 579.83 |
|
|
| QT180667 |
Tirofiban Impurity 67
CAS# NA
M.F.: C22H36N2O5S
M.W.: 440.60 |
|
|
| QT180666 |
Tirofiban Impurity 66
CAS# NA
M.F.: C19H30N2O5S
M.W.: 398.52 |
|
|
| QT180665 |
Tirofiban Impurity 65
CAS# NA
M.F.: C20H32N2O5S
M.W.: 412.54 |
|
|
| QT180664 |
Tirofiban Impurity 64
CAS# NA
M.F.: C21H34N2O5S
M.W.: 426.57 |
|
|
| QT180663 |
Tirofiban Impurity 63
CAS# NA
M.F.: C31H41N3O5S
M.W.: 567.74 |
|
|
| QT180662 |
Tirofiban Impurity 62
CAS# NA
M.F.: C22H30N2O5S
M.W.: 434.55 |
|
|
| QT180661 |
Tirofiban Impurity 61
CAS# NA
M.F.: C19H24N2O5S
M.W.: 392.47 |
|
|
| QT180660 |
Tirofiban Impurity 60
CAS# NA
M.F.: C20H26N2O5S
M.W.: 406.50 |
|
|
| QT180659 |
Tirofiban Impurity 59
CAS# 1134-35-6
M.F.: C12H12N2
M.W.: 184.24 |
|
|
| QT180658 |
Tirofiban Impurity 58
CAS# 6304-31-0
M.F.: C10H15N
M.W.: 149.23 |
|
|
| QT180657 |
Tirofiban Impurity 57
CAS# NA
M.F.: C10H13NO5S
M.W.: 259.28 |
|
|
| QT180656 |
Tirofiban Impurity 56
CAS# NA
M.F.: C11H15NO5S
M.W.: 273.31 |
|
|
| QT180655 |
Tirofiban Impurity 55
CAS# NA
M.F.: C12H17NO5S
M.W.: 287.33 |
|
|
| QR2102122 |
Rivaroxaban Impurity 122
CAS# 28025-61-8
M.F.: C10H12ClNO2
M.W.: 213.66 |
|
|
| QR2102121 |
Rivaroxaban Impurity 121
CAS# 67482-49-9
M.F.: C5H2Cl2OS
M.W.: 181.04 |
|
|
| QR2102120 |
Rivaroxaban Impurity 120
CAS# NA
M.F.: C25H23N5O6
M.W.: 489.48 |
|
|
| QR2102119 |
Rivaroxaban Impurity 119
CAS# NA
M.F.: C21H21N3O5
M.W.: 395.41 |
|
|
| QR2102118 |
Rivaroxaban Impurity 118
CAS# NA
M.F.: C11H10ClNO3
M.W.: 239.66 |
|
|
| QR2102117 |
Rivaroxaban Impurity 117
CAS# NA
M.F.: C10H13NO3
M.W.: 195.22 |
|
|
| QV220504 |
Vedaprofen EP Impurity D
CAS# NA
M.F.: C19H22O2
M.W.: 282.38 |
|
|
| QV220503 |
Vedaprofen EP Impurity C
CAS# NA
M.F.: C18H20O2
M.W.: 268.35 |
|
|
| QB212526 |
Butylphthalide Impurity 26
CAS# NA
M.F.: C24H30O5
M.W.: 398.49 |
|
|
| QP261633 |
Pazopanib Impurity 33
CAS# 1226500-00-0
M.F.: C28H30N4O2S
M.W.: 486.63 |
|
|
| QP261632 |
Pazopanib Impurity 32
CAS# 1072836-76-0
M.F.: C14H17N3O4S2
M.W.: 355.43 |
|
|
| QP261631 |
Pazopanib Impurity 31
CAS# 6949-23-1
M.F.: C7H8N2O4S
M.W.: 216.21 |
|
|
| QP261630 |
Pazopanib Impurity 30
CAS# 1036585-24-6
M.F.: C7H10N2O2S
M.W.: 186.23 |
|
|
| QI091628 |
Ipratropium Bromide Impurity 28
CAS# 30833-12-6
M.F.: C10H17NO3
M.W.: 199.25 |
|
|
| QT041308 |
Trifluridine-13C-15N2
CAS# 2086328-10-9
M.F.: C913CH11F315N2O5
M.W.: 299.18 |
|
|
| QT041307 |
Tipiracil-13C-15N2 HCl
CAS# 183204-72-0 (non-labelled)
M.F.: C813CH11ClN215N2O2 HCl
M.W.: 245.64 36.46 |
|
|
| QP261629 |
Pazopanib Impurity 29
CAS# 412304-82-6
M.F.: C7H8N2O4S
M.W.: 216.21 |
|
|
| QP261628 |
Pazopanib Impurity 28
CAS# 121-03-9
M.F.: C7H7NO5S
M.W.: 217.20 |
|
|
| QP261627 |
Pazopanib Impurity 27
CAS# 80927-55-5
M.F.: C4H3ClN2O
M.W.: 130.53 |
|
|
| QP261626 |
Pazopanib Impurity 26
CAS# 55873-09-1
M.F.: C4H3ClN2O
M.W.: 130.53 |
|
|
| QP261625 |
Pazopanib Impurity 25
CAS# 79173-62-9
M.F.: C8H9N3
M.W.: 147.18 |
|
|
| QP261624 |
Pazopanib Impurity 24
CAS# 221681-92-1
M.F.: C9H11N3
M.W.: 161.20 |
|
|
| QD032050 |
Docetaxel-d9
CAS# 940867-25-4
M.F.: C43H44D9NO14
M.W.: 816.93 |
|
|
| QP180779 |
Pregabalin Impurity 79
CAS# NA
M.F.: C10H17NO2
M.W.: 183.25 |
|
|
| QP180778 |
Pregabalin Impurity 78
CAS# 181289-39-4
M.F.: C10H17NO2
M.W.: 183.25 |
|
|
| QV220502 |
Vedaprofen EP Impurity B
CAS# NA
M.F.: C23H30O2
M.W.: 338.48 |
|
|
| QA261224 |
Azelastine Impurity 24
CAS# NA
M.F.: C7H13NO2
M.W.: 143.18 |
|
|
| QA261223 |
Azelastine Impurity 23
CAS# 1541050-36-5
M.F.: C9H15NO3
M.W.: 185.22 |
|
|
| QV220501 |
Vedaprofen EP Impurity A
CAS# NA
M.F.: C20H24O2
M.W.: 296.40 |
|
|
| QV220500 |
Vedaprofen
CAS# 71109-09-6
M.F.: C19H22O2
M.W.: 282.38 |
|
|
| QV220105 |
Valnemulin hydrochloride EP Impurity E
CAS# NA
M.F.: C22H34O5
M.W.: 378.50 |
|
|
| QV220104 |
Valnemulin hydrochloride EP Impurity D
CAS# NA
M.F.: C5H11NO2
M.W.: 117.15 |
|
|
| QV220103 |
Valnemulin hydrochloride EP Impurity C
CAS# NA
M.F.: C36H61N3O6S
M.W.: 663.95 |
|
|
| QV220102 |
Valnemulin hydrochloride EP Impurity B
CAS# NA
M.F.: C26H43NO4S
M.W.: 465.69 |
|
|
| QV220101 |
Valnemulin hydrochloride EP Impurity A
CAS# NA
M.F.: C31H52N2O6S
M.W.: 580.82 |
|
|
| QV220100 |
Valnemulin hydrochloride
CAS# 133868-46-9
M.F.: C31H53ClN2O5S
M.W.: 601.28 |
|
|
| QE262053 |
Ezetimibe Impurity 53
CAS# 1212276-33-9
M.F.: C14H17NO3
M.W.: 247.29 |
|
|
| QU140400 |
Undecylenic acid
CAS# 112-38-9
M.F.: C11H20O2
M.W.: 184.28 |
|
|
| QR012100 |
Raubasine
CAS# 483-04-5
M.F.: C21H24N2O3
M.W.: 352.43 |
|
|
| QT1406155 |
Tenofovir Impurity 155
CAS# NA
M.F.: C33H49N6O15P
M.W.: 800.75 |
|
|
| QT1406154 |
Tenofovir Impurity 154
CAS# NA
M.F.: C21H29N6O5P
M.W.: 476.47 |
|
|
| QT181700 |
Troxerutin
CAS# NA
M.F.: C33H42O19
M.W.: 742.68 |
|
|
| QC-T180973 |
triallylamine
CAS# 102-70-5
M.F.: C9H15N
M.W.: 137.22 |
|
|
| QC-D090109 |
diallylamine
CAS# 124-02-7
M.F.: C6H11N
M.W.: 97.16 |
|
|
| QT181007 |
Trimipramine maleate EP Impurity G
CAS# NA
M.F.: C15H15N
M.W.: 209.29 |
|
|
| QT181005 |
Trimipramine maleate EP Impurity E
CAS# NA
M.F.: C25H37N3
M.W.: 379.58 |
|
|
| QT181003 |
Trimipramine maleate EP Impurity C
CAS# NA
M.F.: C20H24N2
M.W.: 292.42 |
|
|
| QT181002 |
Trimipramine maleate EP Impurity B
CAS# NA
M.F.: C19H24N2
M.W.: 280.41 |
|
|
| QT181001 |
Trimipramine maleate EP Impurity A
CAS# NA
M.F.: C20H26N2O
M.W.: 310.43 |
|
|
| QT181000 |
Trimipramine maleate
CAS# 521-78-8
M.F.: C24H30N2O4
M.W.: 410.51 |
|
|
| QT011302 |
Tramazoline hydrochloride monohydrate EP Impurity B
CAS# NA
M.F.: C30H38N6O2
M.W.: 514.66 |
|
|
| QT011301 |
Tramazoline hydrochloride monohydrate EP Impurity A
CAS# NA
M.F.: C13H13N3
M.W.: 211.26 |
|
|
| QT011300 |
Tramazoline hydrochloride monohydrate
CAS# 74195-73-6
M.F.: C13H20ClN3O
M.W.: 269.77 |
|
|
| QR2102116 |
Rivaroxaban Impurity 116
CAS# 1616563-62-2
M.F.: C15H17N3O5
M.W.: 319.31 |
|
|
| QA181011 |
Articaine Impurity 11
CAS# 1265892-01-0
M.F.: C13H18N2O5S
M.W.: 314.36 |
|
|
| QT031858 |
alpha-Tocopherol succinate
CAS# 4345-03-3
M.F.: C33H54O5
M.W.: 530.78 |
|
|
| QT151700 |
Tosylchloramide sodium
CAS# NA
M.F.: C7H13ClNNaO5S
M.W.: 281.69 |
|
|
| QT151504 |
Tolnaftate EP Impurity D
CAS# NA
M.F.: C8H11N
M.W.: 121.18 |
|
|
| QT151502 |
Tolnaftate EP Impurity B
CAS# NA
M.F.: C21H14O2S
M.W.: 330.40 |
|
|
| QT151500 |
Tolnaftate
CAS# 2398-96-1
M.F.: C19H17NOS
M.W.: 307.41 |
|
|
| QT151403 |
Tolfenamic acid EP Impurity C
CAS# NA
M.F.: C14H10ClNO
M.W.: 243.69 |
|
|
| QT151402 |
Tolfenamic acid EP Impurity B
CAS# NA
M.F.: C7H8ClN
M.W.: 141.60 |
|
|
| QT151400 |
Tolfenamic acid
CAS# 13710-19-5
M.F.: C14H12ClNO2
M.W.: 261.70 |
|
|
| QT151303 |
Tolbutamide EP Impurity C
CAS# NA
M.F.: C14H21N3O3S
M.W.: 311.40 |
|
|
| QT151302 |
Tolbutamide EP Impurity B
CAS# NA
M.F.: C8H10N2O3S
M.W.: 214.24 |
|
|
| QT151300 |
Tolbutamide
CAS# 64-77-7
M.F.: C12H18N2O3S
M.W.: 270.35 |
|
|
| QC032510 |
Cycloserine Impurity 10
CAS# NA
M.F.: C11H16O3S
M.W.: 228.31 |
|
|
| QC032509 |
Cycloserine Impurity 9
CAS# 129303-70-4
M.F.: C10H14O3S
M.W.: 214.28 |
|
|
| QC032508 |
Cycloserine Impurity 8
CAS# 102439-46-3
M.F.: C9H12O3S
M.W.: 200.25 |
|
|
| QC032507 |
Cycloserine Impurity 7
CAS# 1204-99-5
M.F.: C6H12N4O4
M.W.: 204.18 |
|
|
| QC032506 |
Cycloserine Impurity 6
CAS# 327064-64-2
M.F.: C4H8ClNO2
M.W.: 137.56 |
|
|
| QC032505 |
Cycloserine Impurity 5
CAS# NA
M.F.: C3H5Cl2NO
M.W.: 141.98 |
|
|
| QT090803 |
Tioconazole EP Impurity C
CAS# NA
M.F.: C16H12BrCl3N2OS
M.W.: 466.61 |
|
|
| QC032504 |
Cycloserine Impurity 4
CAS# 32345-44-1
M.F.: C4H8ClNO2
M.W.: 137.56 |
|
|
| QT090802 |
Tioconazole EP Impurity B
CAS# NA
M.F.: C16H12Cl4N2OS
M.W.: 422.16 |
|
|
| QT090801 |
Tioconazole EP Impurity A
CAS# NA
M.F.: C16H14Cl2N2OS
M.W.: 353.27 |
|
|
| QT090800 |
Tioconazole
CAS# 65899-73-2
M.F.: C16H13Cl3N2OS
M.W.: 387.71 |
|
|
| QC032503 |
Cycloserine Impurity 3
CAS# 2788-84-3
M.F.: C4H9NO3
M.W.: 119.12 |
|
|
| QT090706 |
Tiaprofenic acid EP Impurity F
CAS# NA
M.F.: C11H7BrOS
M.W.: 267.14 |
|
|
| QT090705 |
Tiaprofenic acid EP Impurity E
CAS# NA
M.F.: C7H8O2S
M.W.: 156.20 |
|
|
| QT090703 |
Tiaprofenic acid EP Impurity C
CAS# NA
M.F.: C14H12O3S
M.W.: 260.31 |
|
|
| QT090702 |
Tiaprofenic acid EP Impurity B
CAS# NA
M.F.: C13H10O2S
M.W.: 230.28 |
|
|
| QT090701 |
Tiaprofenic acid EP Impurity A
CAS# NA
M.F.: C13H12OS
M.W.: 216.30 |
|
|
| QT090700 |
Tiaprofenic acid
CAS# 33005-95-7
M.F.: C14H12O3S
M.W.: 260.31 |
|
|
| QT0307169 |
Ticagrelor Impurity 169
CAS# NA
M.F.: C28H41ClN9O8S2
M.W.: 731.26 |
|
|
| QT0307168 |
Ticagrelor Impurity 168
CAS# NA
M.F.: C27H42N6O8S
M.W.: 610.72 |
|
|
| QT0307167 |
Ticagrelor Impurity 167
CAS# NA
M.F.: C17H24ClN5O5S
M.W.: 445.92 |
|
|
| QD031240 |
Daclatasvir Impurity 40
CAS# 1007884-60-7
M.F.: C33H39N7O3
M.W.: 581.71 |
|
|
| QD031239 |
Daclatasvir Impurity 39
CAS# NA
M.F.: C36H44N6O4
M.W.: 624.77 |
|
|
| QT090505 |
Tianeptine sodium EP Impurity E
CAS# NA
M.F.: C28H37ClN2O6S
M.W.: 565.12 |
|
|
| QT090504 |
Tianeptine sodium EP Impurity D
CAS# NA
M.F.: C21H23ClN2O4S
M.W.: 434.94 |
|
|
| QT090503 |
Tianeptine sodium EP Impurity C
CAS# NA
M.F.: C14H10ClNO3S
M.W.: 307.75 |
|
|
| QT090502 |
Tianeptine sodium EP Impurity B
CAS# NA
M.F.: C23H29ClN2O4S
M.W.: 465.01 |
|
|
| QT090501 |
Tianeptine sodium EP Impurity A
CAS# NA
M.F.: C9H17BrO2
M.W.: 237.13 |
|
|
| QT090500 |
Tianeptine sodium
CAS# 30123-17-2
M.F.: C21H24ClN2NaO4S
M.W.: 458.93 |
|
|
| QT090400 |
Tiabendazole
CAS# 148-79-8
M.F.: C10H7N3S
M.W.: 201.25 |
|
|
| QA070278 |
Argatroban Impurity 52
CAS# NA
M.F.: C24H38N6O5S
M.W.: 522.66 |
|
|
| QT081604 |
Thiopental sodium and sodium carbonate EP Impurity D
CAS# NA
M.F.: C11H20N2O3S
M.W.: 260.35 |
|
|
| QA070277 |
Argatroban Impurity 51
CAS# NA
M.F.: C25H40N6O5S
M.W.: 536.69 |
|
|
| QT081603 |
Thiopental sodium and sodium carbonate EP Impurity C
CAS# NA
M.F.: C11H18N2O2S
M.W.: 242.34 |
|
|
| QT081601 |
Thiopental sodium and sodium carbonate EP Impurity A
CAS# NA
M.F.: C9H14N2O2S
M.W.: 214.28 |
|
|
| QA1624143 |
Apixaban Impurity 143
CAS# NA
M.F.: C19H16ClN5O2
M.W.: 381.82 |
|
|
| QA1624142 |
Apixaban Impurity 142
CAS# NA
M.F.: C24H23Cl2N5O3
M.W.: 500.38 |
|
|
| QT081600 |
Thiopental sodium and sodium carbonate
CAS# NA
M.F.: C11H17N2NaO2S
M.W.: 264.32 |
|
|
| QA1624141 |
Apixaban Impurity 141
CAS# NA
M.F.: C24H21ClN4O4
M.W.: 464.90 |
|
|
| QA1624140 |
Apixaban Impurity 140
CAS# NA
M.F.: C25H25ClN4O5
M.W.: 496.94 |
|
|
| QA1624139 |
Apixaban Impurity 139
CAS# NA
M.F.: C24H22Cl2N4O4
M.W.: 501.36 |
|
|
| QA1624138 |
Apixaban Impurity 138
CAS# 206753-46-0
M.F.: C12H15NO2
M.W.: 205.25 |
|
|
| QA1624137 |
Apixaban Impurity 137
CAS# NA
M.F.: C12H16ClNO2
M.W.: 241.71 |
|
|
| QA1624136 |
Apixaban Impurity 136
CAS# NA
M.F.: C21H19ClN4O3
M.W.: 410.85 |
|
|
| QA1624135 |
Apixaban Impurity 135
CAS# NA
M.F.: C21H17ClN4O5
M.W.: 440.84 |
|
|
| QA1624134 |
Apixaban Impurity 134
CAS# NA
M.F.: C26H29N5O7
M.W.: 523.54 |
|
|
| QT081400 |
Thiomersal
CAS# 54-64-8
M.F.: C9H9HgNaO2S
M.W.: 404.81 |
|
|
| QT081200 |
Thiamphenicol
CAS# 15318-45-3
M.F.: C12H15Cl2NO5S
M.W.: 356.22 |
|
|
| QR2102115 |
Rivaroxaban Impurity 115
CAS# NA
M.F.: C22H19N3O6
M.W.: 421.40 |
|
|
| QR2102114 |
Rivaroxaban Impurity 114
CAS# NA
M.F.: C22H19N3O6
M.W.: 421.40 |
|
|
| QB192011 |
Bilastine impurity 11
CAS# 874895-87-1
M.F.: C14H19NO
M.W.: 217.31 |
|
|
| QC-D091373 |
N1,N2-dimethylbenzene-1,2-diamine
CAS# 3213-79-4
M.F.: C8H12N2
M.W.: 136.19 |
|
|
| QT081000 |
Thiamazole
CAS# 60-56-0
M.F.: C4H6N2S
M.W.: 114.17 |
|
|
| QC-C081544 |
2-chloro-N-methylaniline
CAS# 932-32-1
M.F.: C7H8ClN
M.W.: 141.6 |
|
|
| QR2102113 |
Rivaroxaban Impurity 113
CAS# 1265617-06-8
M.F.: C22H19N3O6
M.W.: 421.40 |
|
|
| QT052301 |
Tetryzoline hydrochloride EP Impurity A
CAS# NA
M.F.: C11H11N
M.W.: 157.21 |
|
|
| QT052300 |
Tetryzoline hydrochloride
CAS# 522-48-5
M.F.: C13H17ClN2
M.W.: 236.74 |
|
|
| QT052203 |
Tetracaine hydrochloride EP Impurity C
CAS# NA
M.F.: C12H17NO2
M.W.: 207.27 |
|
|
| QT052202 |
Tetracaine hydrochloride EP Impurity B
CAS# NA
M.F.: C11H15NO2
M.W.: 193.24 |
|
|
| QT052201 |
Tetracaine hydrochloride EP Impurity A
CAS# NA
M.F.: C7H7NO2
M.W.: 137.14 |
|
|
| QP181917 |
Prasugrel Impurity Q
CAS# NA
M.F.: C9H11NO2S
M.W.: 197.25 |
|
|
| QT052200 |
Tetracaine hydrochloride
CAS# 136-47-0
M.F.: C15H25ClN2O2
M.W.: 300.82 |
|
|
| QT052110 |
Terfenadine EP Impurity J
CAS# NA
M.F.: C22H35NO3
M.W.: 361.52 |
|
|
| QB261110 |
Benzyl-C8-18-alkyldimethylammonium chlorides
CAS# 63449-41-2
M.F.: C10H16ClN(CH2)n
M.W.: 185.69+(14.02)n |
|
|
| QT052108 |
Terfenadine EP Impurity H
CAS# NA
M.F.: C32H41NO
M.W.: 455.67 |
|
|
| QT052107 |
Terfenadine EP Impurity G
CAS# NA
M.F.: C32H39NO
M.W.: 453.66 |
|
|
| QT052106 |
Terfenadine EP Impurity F
CAS# NA
M.F.: C32H37N
M.W.: 435.64 |
|
|
| QT052105 |
Terfenadine EP Impurity E
CAS# NA
M.F.: C20H31NO3
M.W.: 333.47 |
|
|
| QT052104 |
Terfenadine EP Impurity D
CAS# NA
M.F.: C32H39NO
M.W.: 453.66 |
|
|
| QT052103 |
Terfenadine EP Impurity C
CAS# NA
M.F.: C32H41NO3
M.W.: 487.67 |
|
|
| QT052102 |
Terfenadine EP Impurity B
CAS# NA
M.F.: C32H41NO
M.W.: 455.67 |
|
|
| QM050610 |
Mefenamic Acid Impurity 10
CAS# NA
M.F.: C13H8Cl2O2
M.W.: 267.11 |
|
|
| QT052101 |
Terfenadine EP Impurity A
CAS# NA
M.F.: C32H39NO2
M.W.: 469.66 |
|
|
| QT052100 |
Terfenadine
CAS# 50679-08-8
M.F.: C32H41NO2
M.W.: 471.67 |
|
|
| QF132027 |
Formoterol Impurity 27
CAS# NA
M.F.: C8H11NO3
M.W.: 169.18 |
|
|
| QT130107 |
Temazepam EP Impurity G
CAS# NA
M.F.: C17H15ClN2O2
M.W.: 314.77 |
|
|
| QT130106 |
Temazepam EP Impurity F
CAS# NA
M.F.: C16H13ClN2O2
M.W.: 300.74 |
|
|
| QM121432 |
Milnacipran Impurity 6
CAS# NA
M.F.: C23H24N2O3
M.W.: 376.45 |
|
|
| QF132026 |
Formoterol Impurity 26
CAS# 54255-50-4
M.F.: C8H9NO2
M.W.: 151.16 |
|
|
| QT130105 |
Temazepam EP Impurity E
CAS# NA
M.F.: C16H13ClN2O2
M.W.: 300.74 |
|
|
| QT130104 |
Temazepam EP Impurity D
CAS# NA
M.F.: C17H15ClN2O2
M.W.: 314.77 |
|
|
| QF132025 |
Formoterol Impurity 25
CAS# 903563-43-9
M.F.: C8H7NO3
M.W.: 165.15 |
|
|
| QT130103 |
Temazepam EP Impurity C
CAS# NA
M.F.: C18H15ClN2O3
M.W.: 342.78 |
|
|
| QT130102 |
Temazepam EP Impurity B
CAS# NA
M.F.: C15H11ClN2O2
M.W.: 286.71 |
|
|
| QT130101 |
Temazepam EP Impurity A
CAS# NA
M.F.: C14H12ClNO
M.W.: 245.70 |
|
|
| QT130100 |
Temazepam
CAS# 846-50-4
M.F.: C16H13ClN2O2
M.W.: 300.74 |
|
|
| QA202296 |
Atorvastatin Impurity 96
CAS# 125988-01-4
M.F.: C11H17NO4
M.W.: 227.26 |
|
|
| QA220107 |
Avatrombopag Impurity 7
CAS# 1290121-42-4
M.F.: C29H35ClN6O4S2
M.W.: 631.21 |
|
|
| QA220106 |
Avatrombopag Impurity 6
CAS# NA
M.F.: C31H37Cl3N6O3S2
M.W.: 712.15 |
|
|
| QA220105 |
Avatrombopag Impurity 5
CAS# NA
M.F.: C17H22BrClN4S2
M.W.: 461.87 |
|
|
| QA220104 |
Avatrombopag Impurity 4
CAS# 123971-45-9
M.F.: C7H5ClN2S2
M.W.: 216.71 |
|
|
| QS211703 |
Sulindac EP Impurity C
CAS# NA
M.F.: C20H17FO2S
M.W.: 340.41 |
|
|
| QS211702 |
Sulindac EP Impurity B
CAS# NA
M.F.: C20H17FO4S
M.W.: 372.41 |
|
|
| QL151409 |
Lornoxicam Impurity 9
CAS# NA
M.F.: C6H5ClO4S2
M.W.: 240.68 |
|
|
| QS211701 |
Sulindac EP Impurity A
CAS# NA
M.F.: C20H17FO3S
M.W.: 356.41 |
|
|
| QS211700 |
Sulindac
CAS# 38194-50-2
M.F.: C20H17FO3S
M.W.: 356.41 |
|
|
| QI192223 |
Isavuconazole Impuirty 23
CAS# NA
M.F.: C10H15N3O2
M.W.: 209.24 |
|
|
| QI192222 |
Isavuconazole Impuirty 22
CAS# NA
M.F.: C29H35ClF2N8O5S
M.W.: 681.15 |
|
|
| QI192221 |
Isavuconazole Impuirty 21
CAS# NA
M.F.: C35H37ClF2N8O6S
M.W.: 771.23 |
|
|
| QS211603 |
Sulfinpyrazone EP Impurity C
CAS# NA
M.F.: C23H20N2O4S
M.W.: 420.48 |
|
|
| QI192220 |
Isavuconazole Impuirty 20
CAS# NA
M.F.: C13H17N3O4
M.W.: 279.29 |
|
|
| QS211602 |
Sulfinpyrazone EP Impurity B
CAS# NA
M.F.: C23H20N2O2S
M.W.: 388.48 |
|
|
| QC-E200895 |
3-ethylheptan-2-one
CAS# 6137-09-3
M.F.: C9H18O
M.W.: 142.24 |
|
|
| QS211601 |
Sulfinpyrazone EP Impurity A
CAS# NA
M.F.: C23H20N2O4S
M.W.: 420.48 |
|
|
| QS211600 |
Sulfinpyrazone
CAS# 57-96-5
M.F.: C23H20N2O3S
M.W.: 404.48 |
|
|
| QI192219 |
Isavuconazole Impuirty 19
CAS# NA
M.F.: C35H35ClF2N8O5S HCl
M.W.: 753.22 36.46 |
|
|
| QI192218 |
Isavuconazole Impuirty 18
CAS# NA
M.F.: C32H30ClF2N7O4S
M.W.: 682.14 |
|
|
| QI192217 |
Isavuconazole Impuirty 17
CAS# NA
M.F.: C49H52ClF2N11O11S HCl
M.W.: 1076.52 36.46 |
|
|
| QI242613 |
Ixazomib Impurity M
CAS# NA
M.F.: C14H18BCl3N2O4
M.W.: 395.47 |
|
|
| QI242612 |
Ixazomib Impurity L
CAS# NA
M.F.: C14H18BCl3N2O4
M.W.: 395.47 |
|
|
| QM071202 |
Miglitol Impurity 2
CAS# 1370331-33-1(free base)
M.F.: C8H17NO5 HCl
M.W.: 207.23 36.46 |
|
|
| QS010258 |
Salbutamol Impurity 32
CAS# 108956-88-3
M.F.: C13H19NO4
M.W.: 253.29 |
|
|
| QS211500 |
Sulfadoxine
CAS# 2447-57-6
M.F.: C12H14N4O4S
M.W.: 310.33 |
|
|
| QI242611 |
Ixazomib Impurity K
CAS# NA
M.F.: C14H18BCl3N2O4
M.W.: 395.47 |
|
|
| QI242610 |
Ixazomib Impurity J
CAS# NA
M.F.: C14H18Cl2N2O3
M.W.: 333.21 |
|
|
| QS211407 |
Sulfadimidine EP Impurity G
CAS# NA
M.F.: C12H13ClN4O2S
M.W.: 312.78 |
|
|
| QS211406 |
Sulfadimidine EP Impurity F
CAS# 515-74-2;121-57-3(free base);123333-70-0(hydrate)
M.F.: C6H6NNaO3S
M.W.: 195.17 |
|
|
| QS211405 |
Sulfadimidine EP Impurity E
CAS# NA
M.F.: C8H10N2O3S
M.W.: 214.24 |
|
|
| QD050211 |
Decitabine Impurity 11
CAS# NA
M.F.: C8H12N4O4
M.W.: 228.21 |
|
|
| QS211401 |
Sulfadimidine EP Impurity A
CAS# 127-79-7
M.F.: C11H12N4O2S
M.W.: 264.30 |
|
|
| QS211400 |
Sulfadimidine
CAS# 57-68-1
M.F.: C12H14N4O2S
M.W.: 278.33 |
|
|
| QS211205 |
Sulfadiazine EP Impurity E
CAS# NA
M.F.: C12H12N4O3S
M.W.: 292.31 |
|
|
| QS211203 |
sulfaguanidine; Sulfadiazine EP Impurity C; Sulfadimidine EP Impurity C
CAS# 57-67-0
M.F.: C7H10N4O2S
M.W.: 214.24 |
|
|
| QS211202 |
Sulfadiazine EP Impurity B
CAS# 121-57-3;515-74-2 (Na salt)
M.F.: C6H7NO3S
M.W.: 173.19 |
|
|
| QS211201 |
Sulfadiazine EP Impurity A
CAS# NA
M.F.: C4H5N3
M.W.: 95.10 |
|
|
| QS211200 |
Sulfadiazine;Sulfadimidine EP Impurity B
CAS# 68-35-9
M.F.: C10H10N4O2S
M.W.: 250.28 |
|
|
| QF030337 |
Famciclovir Impurity 37
CAS# NA
M.F.: C14H18ClN5O4
M.W.: 355.78 |
|
|
| QA040641 |
Adefovir dipivoxil
CAS# 142340-99-6
M.F.: C20H32N5O8P
M.W.: 501.47 |
|
|
| QS531509 |
Sucralose EP Impurity I
CAS# NA
M.F.: C6H11ClO5
M.W.: 198.60 |
|
|
| QS531508 |
Sucralose EP Impurity H
CAS# NA
M.F.: C6H10Cl2O4
M.W.: 217.05 |
|
|
| QS531507 |
Sucralose EP Impurity G
CAS# NA
M.F.: C12H18Cl2O8
M.W.: 361.17 |
|
|
| QS531506 |
Sucralose EP Impurity F
CAS# NA
M.F.: C12H20Cl2O9
M.W.: 379.19 |
|
|
| QS531505 |
Sucralose EP Impurity E
CAS# NA
M.F.: C12H20Cl2O9
M.W.: 379.19 |
|
|
| QS531504 |
Sucralose EP Impurity D
CAS# NA
M.F.: C12H20Cl2O9
M.W.: 379.19 |
|
|
| QD160760 |
Dapagliflozin Impurity 60
CAS# NA
M.F.: C16H19ClFN3O3S
M.W.: 387.86 |
|
|
| QS531502 |
Sucralose EP Impurity B
CAS# NA
M.F.: C12H19Cl3O8
M.W.: 397.63 |
|
|
| QI132052 |
Imatinib Impurity 26
CAS# 6232-88-8
M.F.: C8H7BrO2
M.W.: 215.04 |
|
|
| QS531501 |
Sucralose EP Impurity A
CAS# NA
M.F.: C14H21Cl3O9
M.W.: 439.67 |
|
|
| QS201800 |
Streptomycin sulfate
CAS# 3810-74-0
M.F.: C42H84N14O36S3
M.W.: 1457.38 |
|
|
| QC062750 |
Cefazolin Impurity 50
CAS# 26240-90-4
M.F.: C5H8N4O2
M.W.: 156.14 |
|
|
| QP1903104 |
Posaconazole Impurity 104
CAS# NA
M.F.: C11H14N2O2
M.W.: 206.24 |
|
|
| QP1903103 |
Posaconazole Impurity 103
CAS# NA
M.F.: C10H12O2
M.W.: 164.20 |
|
|
| QS200769 |
Sitagliptin Impurity 69
CAS# NA
M.F.: C15H15F3N4O4
M.W.: 372.30 |
|
|
| QC-D090828 |
2,2-dichloro-3,3-dimethylbutane
CAS# 594-84-3
M.F.: C6H12Cl2
M.W.: 155.07 |
|
|
| QS201402 |
Stanozolol EP Impurity B
CAS# NA
M.F.: C21H32O3
M.W.: 332.48 |
|
|
| QS201401 |
Stanozolol EP Impurity A
CAS# NA
M.F.: C20H32O2
M.W.: 304.47 |
|
|
| QS201400 |
Stanozolol
CAS# 10418-03-8
M.F.: C21H32N2O
M.W.: 328.49 |
|
|
| QB180941 |
Brivaracetam Impurity 15
CAS# NA
M.F.: C15H28ClN3O3
M.W.: 333.85 |
|
|
| QB180940 |
Brivaracetam Impurity 14
CAS# NA
M.F.: C7H13ClO2
M.W.: 164.63 |
|
|
| QM071201 |
Miglitol Impurity 1
CAS# NA
M.F.: C8H17NO5
M.W.: 207.22 |
|
|
| QE190104 |
Estazolam Impurity 4
CAS# 49691-65-8
M.F.: C18H14Cl3N3O3
M.W.: 426.68 |
|
|
| QE190103 |
Estazolam Impurity 3
CAS# 10352-28-0
M.F.: C14H10ClNO2
M.W.: 259.69 |
|
|
| QE190102 |
Estazolam Impurity 2
CAS# 31709-27-0
M.F.: C15H10ClN3O
M.W.: 283.71 |
|
|
| QS152004 |
Sotalol hydrochloride EP Impurity D
CAS# NA
M.F.: C12H20N2O3S
M.W.: 272.36 |
|
|
| QS152003 |
Sotalol hydrochloride EP Impurity C
CAS# NA
M.F.: C8H9NO3S
M.W.: 199.23 |
|
|
| QS152002 |
Sotalol hydrochloride EP Impurity B
CAS# NA
M.F.: C12H18N2O3S
M.W.: 270.35 |
|
|
| QS152001 |
Sotalol hydrochloride EP Impurity A
CAS# NA
M.F.: C12H20N2O2S
M.W.: 256.36 |
|
|
| QS152000 |
Sotalol hydrochloride
CAS# 959-24-0
M.F.: C12H21ClN2O3S
M.W.: 308.82 |
|
|
| QA131110 |
Amikacin Impurity 10
CAS# NA
M.F.: C16H32N4O9
M.W.: 424.45 |
|
|
| QA132447 |
Amoxicillin Impurity 21
CAS# 297175-66-7
M.F.: C31H40N6O9S2
M.W.: 704.81 |
|
|
| QB201458 |
Bortezomib Impurity 58
CAS# NA
M.F.: C20H26N4O3
M.W.: 370.45 |
|
|
| QF191632 |
Fosaprepitant Impurity 6
CAS# 502537-07-7
M.F.: C13H12F3NO4
M.W.: 303.23 |
|
|
| QC051400 |
Cefalotin Sodium
CAS# 58-71-9
M.F.: C16H15N2NaO6S2
M.W.: 418.42 |
|
|
| QS151100 |
Sodium salicylate
CAS# 54-21-7
M.F.: C7H5NaO3
M.W.: 160.10 |
|
|
| QD050504 |
BIS THF HNS Derivative 4
CAS# 253265-97-3
M.F.: C11H13NO7
M.W.: 271.22 |
|
|
| QD050503 |
BIS THF HNS Derivative 3
CAS# 799241-86-4
M.F.: C11H13NO7
M.W.: 271.22 |
|
|
| QD050502 |
BIS THF HNS Derivative 2
CAS# 799241-85-3
M.F.: C11H13NO7
M.W.: 271.22 |
|
|
| QD050501 |
BIS THF HNS Derivative 1
CAS# 253265-98-4
M.F.: C11H13NO7
M.W.: 271.22 |
|
|
| QS151000 |
Sodium propionate
CAS# 137-40-6
M.F.: C3H5NaO2
M.W.: 96.06 |
|
|
| QA180703 |
Arginylarginine
CAS# 15483-27-9
M.F.: C12H26N8O3
M.W.: 330.39 |
|
|
| QS150904 |
Sodium ethyl parahydroxybenzoate EP Impurity D
CAS# NA
M.F.: C11H14O3
M.W.: 194.23 |
|
|
| QS150903 |
Sodium ethyl parahydroxybenzoate EP Impurity C
CAS# NA
M.F.: C10H12O3
M.W.: 180.20 |
|
|
| QS150902 |
Sodium ethyl parahydroxybenzoate EP Impurity B
CAS# NA
M.F.: C8H8O3
M.W.: 152.15 |
|
|
| QS150901 |
Sodium ethyl parahydroxybenzoate EP Impurity A
CAS# NA
M.F.: C7H6O3
M.W.: 138.12 |
|
|
| QS150900 |
Sodium ethyl parahydroxybenzoate
CAS# 35285-68-8
M.F.: C9H9NaO3
M.W.: 188.16 |
|
|
| QS150810 |
Sodium caprylate EP Impurity J
CAS# NA
M.F.: C8H14O2
M.W.: 142.20 |
|
|
| QS150809 |
Sodium caprylate EP Impurity I
CAS# NA
M.F.: C11H22O2
M.W.: 170.29 |
|
|
| QS150808 |
Sodium caprylate EP Impurity H
CAS# NA
M.F.: C11H22O2
M.W.: 186.29 |
|
|
| QS150807 |
Sodium caprylate EP Impurity G
CAS# NA
M.F.: C10H20O2
M.W.: 172.26 |
|
|
| QS150806 |
Sodium caprylate EP Impurity F
CAS# NA
M.F.: C9H18O2
M.W.: 158.24 |
|
|
| QS150805 |
Sodium caprylate EP Impurity E
CAS# NA
M.F.: C8H16O2
M.W.: 144.21 |
|
|
| QS150804 |
Sodium caprylate EP Impurity D
CAS# NA
M.F.: C10H20O2
M.W.: 172.26 |
|
|
| QS150803 |
Sodium caprylate EP Impurity C
CAS# NA
M.F.: C9H18O2
M.W.: 158.24 |
|
|
| QS150802 |
Sodium caprylate EP Impurity B
CAS# NA
M.F.: C7H14O2
M.W.: 130.18 |
|
|
| QS150801 |
Sodium caprylate EP Impurity A
CAS# NA
M.F.: C6H12O2
M.W.: 116.16 |
|
|
| QS150800 |
Sodium caprylate
CAS# 1984-06-1
M.F.: C8H15NaO2
M.W.: 166.19 |
|
|
| QS150701 |
Sodium calcium edetate EP Impurity A
CAS# 139-13-9
M.F.: C6H9NO6
M.W.: 191.14 |
|
|
| QS150700 |
Sodium calcium edetate
CAS# 62-33-9
M.F.: C10H12CaN2Na2O8,xH2O
M.W.: 374.27,x18.02 |
|
|
| QE030801 |
Echimidine N-Oxide
CAS# 41093-89-4
M.F.: C20H31NO8
M.W.: 413.46 |
|
|
| QE211800 |
Europine
CAS# 570-19-4
M.F.: C16H27NO6
M.W.: 329.39 |
|
|
| QI142001 |
Intermedine N-Oxide
CAS# 95462-14-9
M.F.: C15H25NO6
M.W.: 315.36 |
|
|
| QI142000 |
Intermedine
CAS# 10285-06-0
M.F.: C15H25NO5
M.W.: 299.36 |
|
|
| QP201660 |
Pantoprazole Impurity 34
CAS# NA
M.F.: C15H13F2N3O4S
M.W.: 369.34 |
|
|
| QC-T180972 |
trimethylamine oxide
CAS# 1184-78-7
M.F.: C3H9NO
M.W.: 75.11 |
|
|
| QC-C081543 |
5-chloro-6-fluoro-1H-benzo[d]imidazole-2(3H)-thione
CAS# 142313-30-2
M.F.: C7H4ClFN2S
M.W.: 202.64 |
|
|
| QC-F122136 |
2-(4-fluorophenyl)-1H-indole
CAS# 782-17-2
M.F.: C14H10FN
M.W.: 211.23 |
|
|
| QC-M050884 |
3-(3-methyl-1H-indol-1-yl)propanoic acid
CAS# 57662-47-2
M.F.: C12H13NO2
M.W.: 203.24 |
|
|
| QC-B051442 |
1-(5-(benzyloxy)-1H-indol-3-yl)-N,N-dimethylmethanamine
CAS# 1453-97-0
M.F.: C18H20N2O
M.W.: 280.36 |
|
|
| QC-M050883 |
5-methyl-1H-indole-2-carboxylic acid
CAS# 10241-97-1
M.F.: C10H9NO2
M.W.: 175.18 |
|
|
| QC-E200894 |
ethyl 2-((2-methyl-1H-indol-3-yl)thio)acetate
CAS# 93187-78-1
M.F.: C13H15NO2S
M.W.: 249.33 |
|
|
| QC-E200893 |
2-(1H-indol-3-yl)ethanol
CAS# 526-55-6
M.F.: C10H11NO
M.W.: 161.20 |
|
|
| QC-M050882 |
methyl 1-benzyl-2-ethyl-5-hydroxy-1H-indole-3-carboxylate
CAS# 184705-03-1
M.F.: C19H19NO3
M.W.: 309.36 |
|
|
| QC-N092032 |
3-nitro-2,6-di(piperidin-1-yl)benzoic acid
CAS# 657350-42-0
M.F.: C17H23N3O4
M.W.: 333.38 |
|
|
| QC-L010301 |
Lactic acid
CAS# 50-21-5
M.F.: C3H6O3
M.W.: 90.08 |
|
|
| QD240319 |
Doxorubicin Impurity 19
CAS# 20982-41-6
M.F.: C21H14O7
M.W.: 378.33 |
|
|
| QC-D090606 |
2,4-dichloro-5-(trichloromethyl)pyrimidine
CAS# 153600-16-9
M.F.: C5HCl5N2
M.W.: 266.34 |
|
|
| QC-D090605 |
2,4-difluoro-5-(trifluoromethyl)pyrimidine
CAS# 153600-17-0
M.F.: C5HF5N2
M.W.: 184.07 |
|
|
| QP190501 |
Pseudoephedrine EP Impurity A
CAS# NA
M.F.: C10H15NO
M.W.: 165.23 |
|
|
| QT022029 |
Terbutaline Impurity 29
CAS# NA
M.F.: C24H30N2O5
M.W.: 426.51 |
|
|
| QT022028 |
Terbutaline Impurity 28
CAS# NA
M.F.: C12H19NO3
M.W.: 225.28 |
|
|
| QB795510 |
epi-002
CAS# 1203490-23-6
M.F.: C21H27ClO5
M.W.: 394.89 |
|
|
| QC-C081542 |
4-(4-chlorothiophen-2-yl)-5-(4-cyclohexylpiperazin-1-yl)thiazol-2-amine
CAS# 570407-42-0
M.F.: C17H23ClN4S2
M.W.: 382.97 |
|
|
| QB201457 |
Bortezomib Impurity 57
CAS# 847644-46-6
M.F.: C17H31BN2O3
M.W.: 322.25 |
|
|
| QC061442 |
Cefdinir Impurity 16
CAS# 79350-14-4
M.F.: C14H12N4O5S2
M.W.: 380.40 |
|
|
| QZ210301 |
Zuclopenthixol Decanoate EP Impurity A
CAS# NA
M.F.: C32H43ClN2O2S
M.W.: 555.21 |
|
|
| QZ210303 |
Zuclopenthixol Decanoate EP Impurity C
CAS# NA
M.F.: C22H25ClN2OS
M.W.: 400.96 |
|
|
| QZ210300 |
Zuclopenthixol Decanoate
CAS# 64053-00-5
M.F.: C32H43ClN2O2S
M.W.: 555.21 |
|
|
| QF041842 |
Fludarabine impurity 16
CAS# 25545-03-3
M.F.: C5H10O5
M.W.: 150.13 |
|
|
| QF041841 |
Fludarabine impurity 15
CAS# NA
M.F.: C10H12FN4O8P
M.W.: 366.20 |
|
|
| QZ090300 |
Zinc undecylenate
CAS# 557-08-4
M.F.: C22H38O4Zn
M.W.: 431.91 |
|
|
| QZ091403 |
Zinc acexamate EP Impurity C
CAS# 1888-91-1
M.F.: C8H13NO2
M.W.: 155.19 |
|
|
| QZ091401 |
Zinc acexamate EP Impurity A
CAS# NA
M.F.: C14H26N2O4
M.W.: 286.37 |
|
|
| QZ091400 |
Zinc acexamate
CAS# 70020-71-2
M.F.: C16H28N2O6Zn
M.W.: 409.78 |
|
|
| QT022026 |
Terbutaline Impurity 26
CAS# NA
M.F.: C12H19NO4
M.W.: 241.28 |
|
|
| QT022025 |
Terbutaline Impurity 25
CAS# NA
M.F.: C22H18O4
M.W.: 346.38 |
|
|
| QT022024 |
Terbutaline Impurity 24
CAS# NA
M.F.: C22H20O3
M.W.: 332.39 |
|
|
| QT022023 |
Terbutaline Impurity 23
CAS# NA
M.F.: C21H18O4
M.W.: 334.37 |
|
|
| QT022022 |
Terbutaline Impurity 22
CAS# NA
M.F.: C28H24O4
M.W.: 424.49 |
|
|
| QE1316104 |
Empagliflozin Impurity 104
CAS# 76049-49-5
M.F.: C13H7ClFIO
M.W.: 360.55 |
|
|
| QL062008 |
Lafutidine Impurity 8
CAS# 169899-15-4
M.F.: C11H15NO4S
M.W.: 257.31 |
|
|
| QL011321 |
Lamotrigine Impurity 21
CAS# NA
M.F.: C9H7Cl2N5O
M.W.: 272.09 |
|
|
| QC031911 |
Cyclophosphamide Impuirty 11
CAS# 40277-05-2
M.F.: C7H15Cl2N2O3P
M.W.: 277.09 |
|
|
| QL062007 |
Lafutidine Impurity 7
CAS# 169899-16-5
M.F.: C11H15NO4S
M.W.: 257.31 |
|
|
| QP132073 |
Pemetrexed Impurity 47
CAS# NA
M.F.: C20H22N4O7
M.W.: 430.41 |
|
|
| QY151205 |
Yohimbine hydrochloride EP Impurity E
CAS# NA
M.F.: C22H28N2O3
M.W.: 368.47 |
|
|
| QY151204 |
Yohimbine hydrochloride EP Impurity D
CAS# NA
M.F.: C21H26N2O3
M.W.: 354.44 |
|
|
| QY151203 |
Yohimbine hydrochloride EP Impurity C
CAS# NA
M.F.: C21H26N2O3
M.W.: 354.44 |
|
|
| QY151202 |
Yohimbine hydrochloride EP Impurity B
CAS# NA
M.F.: C21H26N2O3
M.W.: 354.44 |
|
|
| QY151201 |
Yohimbine hydrochloride EP Impurity A
CAS# NA
M.F.: C21H26N2O3
M.W.: 354.44 |
|
|
| QY151200 |
Yohimbine hydrochloride
CAS# 65-19-0
M.F.: C21H26N2O3 HCl
M.W.: 354.44 36.46 |
|
|
| QS150600 |
Sodium aminosalicylate dihydrate
CAS# 6018-19-5
M.F.: C7H10NNaO5
M.W.: 211.15 |
|
|
| QS150502 |
Sodium amidotrizoate EP Impurity B
CAS# NA
M.F.: C11H10I2N2O4
M.W.: 488.02 |
|
|
| QS150501 |
Sodium amidotrizoate EP Impurity A
CAS# NA
M.F.: C9H7I3N2O3
M.W.: 571.88 |
|
|
| QX250902 |
Xylitol EP Impurity B
CAS# NA
M.F.: C6H14O6
M.W.: 182.17 |
|
|
| QS150500 |
Sodium amidotrizoate
CAS# 737-31-5
M.F.: C11H8I3N2NaO4
M.W.: 635.90 |
|
|
| QX250901 |
Xylitol EP Impurity A
CAS# NA
M.F.: C5H12O5
M.W.: 152.15 |
|
|
| QS150400 |
Sodium alendronate trihydrate
CAS# 121268-17-5
M.F.: C4H18NNaO10P2
M.W.: 325.12 |
|
|
| QS052000 |
Sertaconazole nitrate
CAS# 99592-39-9
M.F.: C20H16Cl3N3O4S
M.W.: 500.78 |
|
|
| QS051300 |
Selenium disulfide
CAS# 7488-56-4
M.F.: S2Se
M.W.: 143.09 |
|
|
| QP261623 |
Pazopanib Impurity 23
CAS# 1296888-46-4
M.F.: C16H20N6
M.W.: 296.37 |
|
|
| QP261622 |
Pazopanib Impurity 22
CAS# NA
M.F.: C4H4N2O2
M.W.: 112.09 |
|
|
| QP261621 |
Pazopanib Impurity 21
CAS# 3551-55-1
M.F.: C6H8N2O2
M.W.: 140.14 |
|
|
| QS011708 |
Saquinavir mesilate EP Impurity H
CAS# NA
M.F.: C38H47N5O5
M.W.: 653.81 |
|
|
| QP261620 |
Pazopanib Impurity 20
CAS# 2369664-16-2
M.F.: C14H15N5O
M.W.: 269.30 |
|
|
| QS011707 |
Saquinavir mesilate EP Impurity G
CAS# NA
M.F.: C39H51N5O6
M.W.: 685.85 |
|
|
| QP261619 |
Pazopanib Impurity 19
CAS# 1226499-98-4
M.F.: C22H22N8
M.W.: 398.46 |
|
|
| QS011706 |
Saquinavir mesilate EP Impurity F
CAS# NA
M.F.: C38H48N6O4
M.W.: 652.83 |
|
|
| QS011705 |
Saquinavir mesilate EP Impurity E
CAS# NA
M.F.: C38H49N5O6
M.W.: 671.83 |
|
|
| QS011704 |
Saquinavir mesilate EP Impurity D
CAS# NA
M.F.: C38H50N6O5
M.W.: 670.84 |
|
|
| QS011703 |
Saquinavir mesilate EP Impurity C
CAS# NA
M.F.: C24H39N3O2
M.W.: 401.59 |
|
|
| QS011702 |
Saquinavir mesilate EP Impurity B
CAS# NA
M.F.: C16H17N3O4
M.W.: 315.32 |
|
|
| QH151601 |
Homopiperazine Impurity 1
CAS# NA
M.F.: C12H18N2O2S
M.W.: 254.35 |
|
|
| QD240318 |
Doxorubicin Impurity 18
CAS# NA
M.F.: C26H25NO10
M.W.: 511.48 |
|
|
| QM201254 |
Montelukast Impurity 28
CAS# NA
M.F.: C34H36ClNOS
M.W.: 542.17 |
|
|
| QM201253 |
Montelukast Impurity 27
CAS# NA
M.F.: C34H36ClNOS
M.W.: 542.17 |
|
|
| QS011701 |
Saquinavir mesilate EP Impurity A
CAS# NA
M.F.: C14H13N3O4
M.W.: 287.27 |
|
|
| QC-H250484 |
5-hydroxyfuran-2-carbaldehyde
CAS# 107997-80-8
M.F.: C5H4O3
M.W.: 112.08 |
|
|
| QS011700 |
Saquinavir mesilate
CAS# 149845-06-7
M.F.: C39H54N6O8S
M.W.: 766.95 |
|
|
| QS011230 |
Salmeterol xinafoate
CAS# 94749-08-3
M.F.: C36H45NO7
M.W.: 603.75 |
|
|
| QB011600 |
Baquiloprim
CAS# 102280-35-3
M.F.: C17H20N6
M.W.: 308.38 |
|
|
| QA042000 |
Aditoprim
CAS# 56066-63-8
M.F.: C15H21N5O2
M.W.: 303.36 |
|
|
| QC-D090827 |
1-(2,5-dichlorophenyl)piperazine dihydrochloride
CAS# 827614-47-1
M.F.: C10H12Cl2N2 2HCl
M.W.: 231.12 72.92 |
|
|
| QC-D090826 |
1-(2,4-dichlorophenyl)piperazine dihydrochloride
CAS# 827614-48-2
M.F.: C10H12Cl2N2 2HCl
M.W.: 231.12 72.92 |
|
|
| QS010410 |
Saccharin sodium
CAS# 128-44-9
M.F.: C7H4NNaO3S
M.W.: 205.17 |
|
|
| QH041814 |
4-beta-Hydroxy Cholesterol-d7
CAS# 1246302-80-6
M.F.: C27H39D7O2
M.W.: 409.70 |
|
|
| QS010400 |
Saccharin
CAS# 81-07-2
M.F.: C7H5NO3S
M.W.: 183.18 |
|
|
| QR212203 |
Rutoside trihydrate EP Impurity C
CAS# NA
M.F.: C15H10O7
M.W.: 302.24 |
|
|
| QR212202 |
Rutoside trihydrate EP Impurity B
CAS# NA
M.F.: C27H30O15
M.W.: 594.52 |
|
|
| QR212201 |
Rutoside trihydrate EP Impurity A
CAS# NA
M.F.: C21H20O12
M.W.: 464.38 |
|
|
| QR212200 |
Rutoside trihydrate
CAS# 250249-75-3
M.F.: C27H36O19
M.W.: 664.56 |
|
|
| QR092609 |
Rizatriptani benzoas EP Impurity I
CAS# NA
M.F.: C14H17N5
M.W.: 255.32 |
|
|
| QR092608 |
Rizatriptani benzoas EP Impurity H
CAS# NA
M.F.: C15H19N5O
M.W.: 285.34 |
|
|
| QR092607 |
Rizatriptani benzoas EP Impurity G
CAS# NA
M.F.: C13H13ClN4
M.W.: 260.72 |
|
|
| QR092606 |
Rizatriptani benzoas EP Impurity F
CAS# NA
M.F.: C13H14N4O
M.W.: 242.28 |
|
|
| QR092605 |
Rizatriptani benzoas EP Impurity E
CAS# NA
M.F.: C16H21N5O2S
M.W.: 347.44 |
|
|
| QR092604 |
Rizatriptani benzoas EP Impurity D
CAS# NA
M.F.: C19H28N5
M.W.: 326.46 |
|
|
| QR092603 |
Rizatriptani benzoas EP Impurity C
CAS# NA
M.F.: C15H19N5
M.W.: 269.34 |
|
|
| QR092602 |
Rizatriptani benzoas EP Impurity B
CAS# NA
M.F.: C28H32N9
M.W.: 494.61 |
|
|
| QR092601 |
Rizatriptani benzoas EP Impurity A
CAS# NA
M.F.: C28H35N7
M.W.: 469.62 |
|
|
| QA1624133 |
Apixaban Impurity 133
CAS# NA
M.F.: C21H18N4O6
M.W.: 422.39 |
|
|
| QC-D130509 |
bis(4-(dimethylamino)phenyl)(4-(methylamino)phenyl)methanol
CAS# 561-41-1
M.F.: C24H29N3O
M.W.: 375.51 |
|
|
| QB151200 |
Benorilate
CAS# 5003-48-5
M.F.: C17H15NO5
M.W.: 313.30 |
|
|
| QR092600 |
Rizatriptani benzoas
CAS# 145202-66-0
M.F.: C22H25N5O2
M.W.: 391.47 |
|
|
| QR091905 |
Risedronate sodium 2.5-hydrate EP Impurity E
CAS# NA
M.F.: C7H11NO6P2
M.W.: 267.11 |
|
|
| QP122418 |
Plerixafor Impurity R
CAS# NA
M.F.: C28H53N8O
M.W.: 517.77 |
|
|
| QR091904 |
Risedronate sodium 2.5-hydrate EP Impurity D
CAS# NA
M.F.: C7H7NO2
M.W.: 137.14 |
|
|
| QR091903 |
Risedronate sodium 2.5-hydrate EP Impurity C
CAS# NA
M.F.: C7H11NO7P2
M.W.: 283.11 |
|
|
| QR091902 |
Risedronate sodium 2.5-hydrate EP Impurity B
CAS# NA
M.F.: C7H11NO7P2
M.W.: 283.11 |
|
|
| QR091901 |
Risedronate sodium 2.5-hydrate EP Impurity A
CAS# NA
M.F.: C14H18N2O12P4
M.W.: 530.19 |
|
|
| QC162010 |
Camptothecin Impurity 10
CAS# 119403-33-7
M.F.: C20H14N2O4
M.W.: 346.34 |
|
|
| QC162009 |
11-methoxycamptothecin
CAS# 70906-25-1
M.F.: C21H18N2O5
M.W.: 378.38 |
|
|
| QC162008 |
(S)-9-Methoxy Camptothecin
CAS# 39026-92-1
M.F.: C21H18N2O5
M.W.: 378.38 |
|
|
| QR091900 |
Risedronate sodium 2.5-hydrate
CAS# 329003-65-8
M.F.: C7H10NNaO7P2,2½H2O
M.W.: 350.13 |
|
|
| QC-T180971 |
3,4,8-trimethyl-3H-imidazo[4,5-f]quinoxalin-2-amine
CAS# 95896-78-9
M.F.: C12H13N5
M.W.: 227.27 |
|
|
| QC-D090524 |
2-(diethylamino)ethanol
CAS# 100-37-8
M.F.: C6H15NO
M.W.: 117.19 |
|
|
| QC181916 |
Crisaborole Impurity 16
CAS# 2268785-42-6
M.F.: C14H6D4BNO3
M.W.: 255.07 |
|
|
| QV010713 |
Valganciclovir Impurity 13
CAS# NA
M.F.: C14H22N6O5
M.W.: 354.36 |
|
|
| QP090307 |
Picosulfate Impurity 7
CAS# 36175-10-7
M.F.: C20H16NNaO6S
M.W.: 421.40 |
|
|
| QV010712 |
Valganciclovir Impurity 12
CAS# NA
M.F.: C14H22N6O5
M.W.: 354.36 |
|
|
| QM040139 |
Midazolam Impurity 13
CAS# 60656-76-0
M.F.: C16H11ClFN3O3
M.W.: 347.73 |
|
|
| QC0303100 |
Cinacalcet Impurity 100
CAS# 3082-62-0
M.F.: C12H13N
M.W.: 171.24 |
|
|
| QC030399 |
Cinacalcet Impurity 99
CAS# 3906-16-9
M.F.: C12H13N
M.W.: 171.24 |
|
|
| QC030398 |
Cinacalcet Impurity 98
CAS# 64189-17-9
M.F.: C10H9F3O
M.W.: 202.17 |
|
|
| QC030397 |
Cinacalcet Impurity 97
CAS# 67801-07-4
M.F.: C10H7F3O2
M.W.: 216.16 |
|
|
| QC-T180970 |
(3-(trifluoromethyl)phenyl)methanol
CAS# 349-75-7
M.F.: C8H7F3O
M.W.: 176.14 |
|
|
| QC-T180969 |
3-(trifluoromethyl)phenol
CAS# 98-17-9
M.F.: C7H5F3O
M.W.: 162.11 |
|
|
| QR091303 |
Rilmenidine dihydrogen phosphate EP Impurity C
CAS# NA
M.F.: C17H26N2O
M.W.: 274.40 |
|
|
| QR091302 |
Rilmenidine dihydrogen phosphate EP Impurity B
CAS# NA
M.F.: C10H17ClN2O
M.W.: 216.71 |
|
|
| QR091301 |
Rilmenidine dihydrogen phosphate EP Impurity A
CAS# NA
M.F.: C10H18N2O2
M.W.: 198.26 |
|
|
| QR091300 |
Rilmenidine dihydrogen phosphate
CAS# 85409-38-7
M.F.: C10H19N2O5P
M.W.: 278.24 |
|
|
| QS060286 |
Sofosbuvir Impurity 86
CAS# NA
M.F.: C22H30N3O10P
M.W.: 527.46 |
|
|
| QC-T180968 |
2-(trifluoromethyl)benzaldehyde
CAS# 447-61-0
M.F.: C8H5F3O
M.W.: 174.12 |
|
|
| QC-T180967 |
4-(trifluoromethyl)benzaldehyde
CAS# 455-19-6
M.F.: C8H5F3O
M.W.: 174.12 |
|
|
| QR090705 |
Rifabutin EP Impurity E
CAS# NA
M.F.: C44H60N4O10
M.W.: 804.97 |
|
|
| QR090704 |
Rifabutin EP Impurity D
CAS# NA
M.F.: C37H47N3O11
M.W.: 709.78 |
|
|
| QR090703 |
Rifabutin EP Impurity C
CAS# NA
M.F.: C46H60N4O11
M.W.: 844.99 |
|
|
| QR090702 |
Rifabutin EP Impurity B
CAS# NA
M.F.: C37H46N2O12
M.W.: 710.77 |
|
|
| QR090701 |
Rifabutin EP Impurity A
CAS# NA
M.F.: C9H17NO
M.W.: 155.24 |
|
|
| QR090700 |
Rifabutin
CAS# 72559-06-9
M.F.: C46H62N4O11
M.W.: 847.00 |
|
|
| QT150200 |
Tobramycin
CAS# 32986-56-4
M.F.: C18H37N5O9
M.W.: 467.51 |
|
|
| QP1903102 |
Posaconazole Impurity 102
CAS# NA
M.F.: C36H40F2N8O5
M.W.: 702.75 |
|
|
| QQ211403 |
Quinidine sulfate EP Impurity C
CAS# NA
M.F.: C20H26N2O2
M.W.: 326.43 |
|
|
| QP1903101 |
Posaconazole Impurity 101
CAS# NA
M.F.: C37H40F2N8O5
M.W.: 714.76 |
|
|
| QQ211402 |
Quinidine sulfate EP Impurity B
CAS# NA
M.F.: C19H22N2O
M.W.: 294.39 |
|
|
| QQ211401 |
Quinidine sulfate EP Impurity A
CAS# NA
M.F.: C20H24N2O2
M.W.: 324.42 |
|
|
| QC-M151807 |
2-(2-morpholinoethoxy)ethanamine
CAS# 20207-13-0
M.F.: C8H18N2O2
M.W.: 174.24 |
|
|
| QC-M151806 |
2-(2-morpholinoethoxy)ethanol
CAS# 3603-45-0
M.F.: C8H17NO3
M.W.: 175.23 |
|
|
| QP252100 |
Pyrimethamine
CAS# 58-14-0
M.F.: C12H13ClN4
M.W.: 248.71 |
|
|
| QT150211 |
Tobramycin Impurity 11
CAS# NA
M.F.: C19H38N6O10
M.W.: 510.54 |
|
|
| QP252002 |
Pyridostigmine bromide EP Impurity B
CAS# NA
M.F.: C6H8NO
M.W.: 110.13 |
|
|
| QP252001 |
Pyridostigmine bromide EP Impurity A
CAS# NA
M.F.: C8H10N2O2
M.W.: 166.18 |
|
|
| QT150210 |
Tobramycin Impurity 10
CAS# 51736-77-7
M.F.: C19H38N6O10
M.W.: 510.54 |
|
|
| QP252000 |
Pyridostigmine bromide
CAS# 101-26-8
M.F.: C9H13BrN2O2
M.W.: 261.12 |
|
|
| QP181400 |
Pyrazinamide
CAS# 98-96-4
M.F.: C5H5N3O
M.W.: 123.11 |
|
|
| QP251904 |
Pyrantel embonate EP Impurity D
CAS# NA
M.F.: C6H12N2
M.W.: 112.17 |
|
|
| QP251903 |
Pyrantel embonate EP Impurity C
CAS# NA
M.F.: C5H4OS
M.W.: 112.15 |
|
|
| QP251902 |
Pyrantel embonate EP Impurity B
CAS# NA
M.F.: C11H16N2OS
M.W.: 224.32 |
|
|
| QP251901 |
Pyrantel embonate EP Impurity A
CAS# NA
M.F.: C11H14N2S
M.W.: 206.31 |
|
|
| QP251900 |
Pyrantel embonate
CAS# 22204-24-6
M.F.: C34H30N2O6S
M.W.: 594.68 |
|
|
| QP152105 |
Protirelin EP Impurity E
CAS# NA
M.F.: C11H14N4O2
M.W.: 234.25 |
|
|
| QP152104 |
Protirelin EP Impurity D
CAS# NA
M.F.: C16H21N5O5
M.W.: 363.37 |
|
|
| QA031229 |
Aciclovir Impurity 29
CAS# 374697-95-7
M.F.: C8H11N5O3
M.W.: 225.20 |
|
|
| QP152103 |
Protirelin EP Impurity C
CAS# NA
M.F.: C11H14N4O4
M.W.: 266.25 |
|
|
| QP152102 |
Protirelin EP Impurity B
CAS# NA
M.F.: C16H22N6O4
M.W.: 362.38 |
|
|
| QP152101 |
Protirelin EP Impurity A
CAS# NA
M.F.: C16H22N6O4
M.W.: 362.38 |
|
|
| QP152100 |
Protirelin
CAS# 24305-27-9
M.F.: C16H22N6O4
M.W.: 362.38 |
|
|
| QO121630 |
Olaparib Impurity 4
CAS# NA
M.F.: C22H14FN5O3
M.W.: 415.38 |
|
|
| QO121629 |
Olaparib Impurity 3
CAS# NA
M.F.: C16H12N2O3
M.W.: 280.28 |
|
|
| QP151803 |
Propyphenazone EP Impurity C
CAS# NA
M.F.: C17H24N2O
M.W.: 272.39 |
|
|
| QO121628 |
Olaparib Impurity 2
CAS# NA
M.F.: C18H16FN3O2
M.W.: 325.34 |
|
|
| QS052202 |
Sevelamer Impurity 2
CAS# NA
M.F.: C9H18N2O
M.W.: 170.25 |
|
|
| QP151802 |
Propyphenazone EP Impurity B
CAS# NA
M.F.: C14H18N2O
M.W.: 230.31 |
|
|
| QS052201 |
Sevelamer Impurity 1
CAS# 13348-89-5
M.F.: C6H13NO2
M.W.: 131.17 |
|
|
| QP151801 |
Propyphenazone EP Impurity A
CAS# NA
M.F.: C11H12N2O
M.W.: 188.23 |
|
|
| QP151800 |
Propyphenazone
CAS# 479-92-5
M.F.: C14H18N2O
M.W.: 230.31 |
|
|
| QO121913 |
Orlistat Impurity 13
CAS# 130676-63-0
M.F.: C28H53NO3
M.W.: 451.73 |
|
|
| QC-H052409 |
(S)-3-hexyl-6-undecyl-5,6-dihydro-2H-pyran-2-one
CAS# 130676-64-1
M.F.: C22H40O2
M.W.: 336.55 |
|
|
| QP151700 |
Propantheline bromide
CAS# 50-34-0
M.F.: C23H30BrNO3
M.W.: 448.39 |
|
|
| QO121912 |
(R,S,S,S)-Orlistat
CAS# 104872-28-8
M.F.: C29H53NO5
M.W.: 495.73 |
|
|
| QP151602 |
Propacetamol hydrochloride EP Impurity B
CAS# NA
M.F.: C6H7NO
M.W.: 109.13 |
|
|
| QP151601 |
Propacetamol hydrochloride EP Impurity A
CAS# NA
M.F.: C8H9NO2
M.W.: 151.16 |
|
|
| QP151600 |
Propacetamol hydrochloride
CAS# 66532-86-3
M.F.: C14H21ClN2O3
M.W.: 300.78 |
|
|
| QP151501 |
Promazine hydrochloride EP Impurity A
CAS# NA
M.F.: C17H20N2OS
M.W.: 300.42 |
|
|
| QP151500 |
Promazine hydrochloride
CAS# 53-60-1
M.F.: C17H21ClN2S
M.W.: 320.88 |
|
|
| QP150704 |
Proguanil hydrochloride EP Impurity D
CAS# NA
M.F.: C8H19N5
M.W.: 185.27 |
|
|
| QP150703 |
Proguanil hydrochloride EP Impurity C
CAS# NA
M.F.: C14H13Cl2N5
M.W.: 322.19 |
|
|
| QP150702 |
Proguanil hydrochloride EP Impurity B
CAS# NA
M.F.: C6H6ClN
M.W.: 127.57 |
|
|
| QC-H250483 |
4,4'-(hydrazine-1,2-diyl)diphenol
CAS# 158905-63-6
M.F.: C12H12N2O2
M.W.: 216.24 |
|
|
| QP150701 |
Proguanil hydrochloride EP Impurity A
CAS# NA
M.F.: C5H10N4
M.W.: 126.16 |
|
|
| QP150700 |
Proguanil hydrochloride
CAS# 637-32-1
M.F.: C11H17Cl2N5
M.W.: 290.19 |
|
|
| QP150300 |
Prochlorperazine maleate
CAS# 84-02-6
M.F.: C28H32ClN3O8S
M.W.: 606.09 |
|
|
| QP150204 |
Probenecid EP Impurity D
CAS# NA
M.F.: C15H23NO4S
M.W.: 313.41 |
|
|
| QM050609 |
Mefenamic Acid Impurity 9
CAS# NA
M.F.: C14H9ClO4
M.W.: 276.67 |
|
|
| QP150203 |
Probenecid EP Impurity C
CAS# NA
M.F.: C19H32N2O3S
M.W.: 368.53 |
|
|
| QM050608 |
Mefenamic Acid Impurity 8
CAS# NA
M.F.: C13H8Cl2O2
M.W.: 267.11 |
|
|
| QM050607 |
Mefenamic Acid Impurity 7
CAS# NA
M.F.: C13H8Cl2O2
M.W.: 267.11 |
|
|
| QP150202 |
Probenecid EP Impurity B
CAS# NA
M.F.: C13H21NO2S
M.W.: 255.38 |
|
|
| QP150201 |
Probenecid EP Impurity A
CAS# NA
M.F.: C7H6O5S
M.W.: 202.18 |
|
|
| QP150200 |
Probenecid
CAS# 57-66-9
M.F.: C13H19NO4S
M.W.: 285.36 |
|
|
| QB091612 |
Biapenem Impurity 12
CAS# NA
M.F.: C30H36N8O8S2
M.W.: 700.79 |
|
|
| QM050606 |
Mefenamic Acid Impurity 6
CAS# NA
M.F.: C13H8Cl2O2
M.W.: 267.11 |
|
|
| QP092100 |
Primaquine diphosphate
CAS# 63-45-6
M.F.: C15H27N3O9P2
M.W.: 455.34 |
|
|
| QM052901 |
Metanephrine Impurity 1
CAS# NA
M.F.: C10H15NO3
M.W.: 197.23 |
|
|
| QC-A030518 |
(R)-2-(N-acetylacetamido)-3-mercaptopropanoic acid
CAS# 74401-71-1
M.F.: C7H11NO4S
M.W.: 205.23 |
|
|
| QG123300 |
Glycodeoxycholic acid
CAS# 360-65-6
M.F.: C26H43NO5
M.W.: 449.62 |
|
|
| QT212400 |
Taurodeoxycholic Acid
CAS# 516-50-7
M.F.: C26H45NO6S
M.W.: 499.70 |
|
|
| QG123200 |
Glycochenodeoxycholic acid
CAS# 640-79-9
M.F.: C26H43NO5
M.W.: 449.62 |
|
|
| QT211500 |
Taurochenodeoxycholic Acid
CAS# 516-35-8
M.F.: C26H45NO6S
M.W.: 499.70 |
|
|
| QP012604 |
Prazepam EP Impurity D
CAS# NA
M.F.: C19H17BrClNO2
M.W.: 406.70 |
|
|
| QL130627 |
Lamivudine Impurity 27
CAS# NA
M.F.: C14H23ClO3S
M.W.: 306.85 |
|
|
| QP012603 |
Prazepam EP Impurity C
CAS# NA
M.F.: C13H10ClNO
M.W.: 231.68 |
|
|
| QP012602 |
Prazepam EP Impurity B
CAS# NA
M.F.: C17H16ClNO
M.W.: 285.77 |
|
|
| QP012601 |
Prazepam EP Impurity A
CAS# NA
M.F.: C15H11ClN2O
M.W.: 270.71 |
|
|
| QP012600 |
Prazepam
CAS# 2955-38-6
M.F.: C19H17ClN2O
M.W.: 324.8 |
|
|
| QL130626 |
Lamivudine Impurity 26
CAS# NA
M.F.: C18H27N3O4S
M.W.: 381.49 |
|
|
| QL130625 |
Lamivudine Impurity 25
CAS# NA
M.F.: C18H26N2O5S
M.W.: 382.47 |
|
|
| QL130624 |
Lamivudine Impurity 24
CAS# NA
M.F.: C7H13N3OSi
M.W.: 183.28 |
|
|
| QL130623 |
Lamivudine Impurity 23
CAS# NA
M.F.: C10H21N3OSi2
M.W.: 255.46 |
|
|
| QP161700 |
potassium acetate
CAS# 127-08-2
M.F.: C2H3KO2
M.W.: 98.14 |
|
|
| QL130622 |
Lamivudine Impurity 22
CAS# NA
M.F.: C14H24O4S
M.W.: 288.40 |
|
|
| QC-I191528 |
isopentane
CAS# 78-78-4
M.F.: C5H12
M.W.: 72.15 |
|
|
| QT081535 |
Theophylline Impurity 9
CAS# NA
M.F.: C7H7N5O3
M.W.: 209.16 |
|
|
| QT081534 |
Theophylline Impurity 8
CAS# NA
M.F.: C7H7N5O3
M.W.: 209.16 |
|
|
| QT081533 |
Theophylline Impurity 7
CAS# NA
M.F.: C6H8N4O3
M.W.: 184.15 |
|
|
| QT081532 |
Theophylline Impurity 6
CAS# NA
M.F.: C5H7N3O2
M.W.: 141.13 |
|
|
| QT081531 |
Theophylline Impurity 5
CAS# NA
M.F.: C7H10N4O3
M.W.: 198.18 |
|
|
| QO121500 |
Olodaterol
CAS# 868049-49-4
M.F.: C21H26N2O5
M.W.: 386.44 |
|
|
| QC-H250482 |
N-(4-hydroxycyclohexyl)acetamide
CAS# 23363-88-4
M.F.: C8H15NO2
M.W.: 157.21 |
|
|
| QL1412111 |
Linagliptin Impurity 111
CAS# NA
M.F.: C16H15BrN6O2
M.W.: 403.23 |
|
|
| QL1412110 |
Linagliptin Impurity 110
CAS# NA
M.F.: C20H18N6O3
M.W.: 390.40 |
|
|
| QL1412109 |
Linagliptin Impurity 109
CAS# 188111-79-7
M.F.: C10H20N2O2
M.W.: 200.28 |
|
|
| QL1412108 |
Linagliptin Impurity 108
CAS# 216854-23-8
M.F.: C10H20N2O2
M.W.: 200.28 |
|
|
| QL1412107 |
Linagliptin Impurity 107
CAS# 551-93-9
M.F.: C8H9NO
M.W.: 135.16 |
|
|
| QC-T051816 |
1-(4-(tert-butyl)-2,6-dimethylphenyl)ethanone
CAS# 2040-10-0
M.F.: C14H20O
M.W.: 204.31 |
|
|
| QC-D090825 |
4,4'-Dihydroxyazobenzene
CAS# 2050-16-0
M.F.: C12H10N2O2
M.W.: 214.22 |
|
|
| QF012218 |
Favipiravir Impurity 18
CAS# 2305633-62-7
M.F.: C5H2BrN3O
M.W.: 199.99 |
|
|
| QF012217 |
Favipiravir Impurity 17
CAS# NA
M.F.: C5HBrFN3
M.W.: 201.98 |
|
|
| QF012216 |
Favipiravir Impurity 16
CAS# NA
M.F.: C5HClFN3
M.W.: 157.53 |
|
|
| QF012215 |
Favipiravir Impurity 15
CAS# 1351238-11-3
M.F.: C5HBr2N3
M.W.: 262.89 |
|
|
| QF012214 |
Favipiravir Impurity 14
CAS# 356783-49-8
M.F.: C5HClFN3
M.W.: 157.53 |
|
|
| QF012213 |
Favipiravir Impurity 13
CAS# 356783-29-4
M.F.: C5H3F2N3O
M.W.: 159.09 |
|
|
| QF012212 |
Favipiravir Impurity 12
CAS# 1207614-48-9
M.F.: C5H2FN3
M.W.: 123.09 |
|
|
| QE180401 |
Erdosteine Impuirty 1
CAS# NA
M.F.: C12H20N2O6S3
M.W.: 384.49 |
|
|
| QE180400 |
Erdosteine
CAS# 84611-23-4
M.F.: C8H11NO4S2
M.W.: 249.31 |
|
|
| QC-H052408 |
hexan-2-ol
CAS# 626-93-7
M.F.: C6H14O
M.W.: 102.17 |
|
|
| QC-M050881 |
4-methylpentan-2-ol
CAS# 108-11-2
M.F.: C6H14O
M.W.: 102.17 |
|
|
| QC-P051602 |
hexan-3-ol
CAS# 623-37-0
M.F.: C6H14O
M.W.: 102.17 |
|
|
| QC-P051601 |
heptan-2-ol
CAS# 543-49-7
M.F.: C7H16O
M.W.: 116.20 |
|
|
| QC-P051407 |
pentan-2-ol
CAS# 6032-29-7
M.F.: C5H12O
M.W.: 88.15 |
|
|
| QC-M050880 |
2-methylbutan-2-ol
CAS# 75-85-4
M.F.: C5H12O
M.W.: 88.15 |
|
|
| QC-M050879 |
2-methylpropan-1-ol
CAS# 78-83-1
M.F.: C4H10O
M.W.: 74.12 |
|
|
| QC-B212032 |
butan-2-ol
CAS# 78-92-2
M.F.: C4H10O
M.W.: 74.12 |
|
|
| QB151440 |
Bromfenac sodium Hydrate
CAS# 120638-55-3
M.F.: C15H11BrNNaO3 3/2H2O
M.W.: 356.15 27.03 |
|
|
| QC-D090824 |
1,1-diethoxyethane
CAS# 105-57-7
M.F.: C6H14O2
M.W.: 118.17 |
|
|
| QT041268 |
Tadalafil Impuirty 68
CAS# NA
M.F.: C22H21N3O5
M.W.: 407.42 |
|
|
| QT041267 |
Tadalafil Impuirty 67
CAS# NA
M.F.: C22H21N3O5
M.W.: 407.42 |
|
|
| QT041266 |
Tadalafil Impuirty 66
CAS# NA
M.F.: C22H21N3O5
M.W.: 407.42 |
|
|
| QE1316103 |
Empagliflozin Impurity 103
CAS# NA
M.F.: C23H27ClO7
M.W.: 450.91 |
|
|
| QC-M050878 |
8-methoxy-1,2-dihydronaphthalene
CAS# 60573-59-3
M.F.: C11H12O
M.W.: 160.21 |
|
|
| QC-T080906 |
2-(thiophen-2-yl)ethanol
CAS# 5402-55-1
M.F.: C6H8OS
M.W.: 128.19 |
|
|
| QN060454 |
Nifedipine Impurity 54
CAS# NA
M.F.: C15H16N4O4
M.W.: 316.31 |
|
|
| QN140405 |
Nintedanib E-isomer
CAS# NA
M.F.: C31H33N5O4
M.W.: 539.62 |
|
|
| QT0307166 |
Ticagrelor Impurity 166
CAS# 187666-88-2
M.F.: C7H10N2O2S
M.W.: 186.23 |
|
|
| QU180109 |
Urapidil Impurity 9
CAS# NA
M.F.: C6H8N2O3
M.W.: 156.14 |
|
|
| QC-T080905 |
thiazol-4-amine hydrochloride
CAS# 59134-95-1
M.F.: C3H5ClN2S
M.W.: 136.60 |
|
|
| QC061737 |
Cefoperazone Impurity 11
CAS# NA
M.F.: C24H29N9O7S2
M.W.: 619.67 |
|
|
| QS052403 |
Selexipag Impurity 3
CAS# NA
M.F.: C7H15NO
M.W.: 129.20 |
|
|
| QT201819 |
Tolterodine Impurity 19
CAS# 194482-41-2 (free base)
M.F.: C19H25NO HCl
M.W.: 283.41 36.46 |
|
|
| QR1922107 |
N-Desmethyl Rosuvastatin Disodium Salt
CAS# 371775-74-5 (free base)
M.F.: C21H24FN3Na2O6S
M.W.: 511.47 |
|
|
| QF012211 |
Favipiravir Impurity 11
CAS# 81411-78-1
M.F.: C5H3N3O
M.W.: 121.10 |
|
|
| QF012210 |
Favipiravir Impurity 10
CAS# 55557-52-3
M.F.: C5H2ClN3
M.W.: 139.54 |
|
|
| QE1316102 |
Empagliflozin Impurity 102
CAS# NA
M.F.: C25H29ClO8
M.W.: 492.95 |
|
|
| QE1316101 |
Empagliflozin Impurity 101
CAS# NA
M.F.: C23H27BrO7
M.W.: 495.36 |
|
|
| QE1316100 |
Empagliflozin Impurity 100
CAS# NA
M.F.: C29H33ClO10
M.W.: 577.02 |
|
|
| QE131699 |
Empagliflozin Impurity 99
CAS# NA
M.F.: C29H33ClO10
M.W.: 577.02 |
|
|
| QE131698 |
Empagliflozin Impurity 98
CAS# NA
M.F.: C29H33ClO10
M.W.: 577.02 |
|
|
|
